Sentence,class,file
e-mail: eunoklee@snu.ac.kr and hanglee@snu.ac.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b3/38/jvms-76-667.PMC4073335.pdf
e- mail: sshigeru@iwate-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ad/00/jvms-76-677.PMC4073336.pdf
e-mail: tamuray@rakuno.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/84/8b/jvms-76-685.PMC4073337.pdf
Available at http://www.danmap.org/.,Non-OADS,/arxiv_data1/oa_pdf/84/8b/jvms-76-685.PMC4073337.pdf
"“Joint FAO/OIE/WHO expert workshop on non-human antimicrobial usage and antimicrobial resistance: scientific assessment,” Available at http://www.who.int/food-safety/publications/micro/en/amr.pdf.",Non-OADS,/arxiv_data1/oa_pdf/84/8b/jvms-76-685.PMC4073337.pdf
Available at http://www.fda.gov/AnimalVeterinary/New-sEvents/CVMUpdates/ucm133743.htm (online).,Non-OADS,/arxiv_data1/oa_pdf/84/8b/jvms-76-685.PMC4073337.pdf
1996: Available at http://www.fda.gov/AnimalVeteri-nary/SafetyHealth/AntimicrobialResistance/NationalAntimicro - bialResistanceMonitoringSystem/default.htm (online).,Non-OADS,/arxiv_data1/oa_pdf/84/8b/jvms-76-685.PMC4073337.pdf
e-mail: sfurusa@hiroshima-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d2/d5/jvms-76-693.PMC4073338.pdf
e-mail: azu05pooh@hotmail.com ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/29/92/jvms-76-705.PMC4073339.pdf
e-mail: kasuyaka@aqs.maff.go.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1b/14/jvms-76-715.PMC4073340.pdf
e-mail: denchu@fukuoka-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c8/fc/jvms-76-719.PMC4073341.pdf
e-mail: uenohiro@rakuno.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/10/8a/jvms-76-723.PMC4073342.pdf
e-mail: kakuma@ntu.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ca/12/jvms-76-729.PMC4073343.pdf
e-mail: shirota@azabu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4f/fb/jvms-76-735.PMC4073344.pdf
e-mail: m-koba@nvlu.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ba/fa/jvms-76-741.PMC4073345.pdf
e-mail: andj67@korea.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0a/af/jvms-76-745.PMC4073346.pdf
e-mail: auchidak@mail.ecc.u-tokyo.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d7/33/jvms-76-751.PMC4073347.pdf
e-mail: kikusui@azabu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bd/44/jvms-76-757.PMC4073348.pdf
e-mail: maedas@hyo-med.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8a/00/jvms-76-763.PMC4073349.pdf
e-mail: ahndc@jbnu.ac.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2c/1d/jvms-76-767.PMC4073350.pdf
e-mail: tsubota@vetmed.hokudai.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ab/66/jvms-76-773.PMC4073351.pdf
e-mail: jpark@jbnu.ac.kr ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/78/39/jvms-76-777.PMC4073352.pdf
http://www.racds.org/RACDS/Pathways/FRACDS‑SFS/ OMSTrainingPathway/Handbook/RACDS_Content/Pathways/ OMS‑Training/Handbook.aspx?hkey=ded233e2‑e403‑4105‑82d6‑ 38cbaf0c609b Cite this article as:  Heggie AA.,Non-OADS,/arxiv_data1/oa_pdf/80/19/AMS-4-1.PMC4073449.pdf
A systematic search on National  Library of Medicine (PubMed/Medlinehttp://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/05/5e/AMS-4-9.PMC4073471.pdf
Available from: http://www.xilloc.com/patients/stories/ total‑mandibular‑implant/ [Last accessed on 2013 Jul 7].,Non-OADS,/arxiv_data1/oa_pdf/05/5e/AMS-4-9.PMC4073471.pdf
4:203. http://dx.doi.org/10.1038/msb.2008.43 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1016/j.molcel.2008.01.021 .,OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
391: 671– 678. http://dx.doi.org/10.1016/ j.jmb.2009.06.043 .,OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
104: 6043– 6048. http://dx.doi.org/10.1073/ pnas.0606717104 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/ 10.1073/pnas.76.10.5090 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
370: 609 – 619. http://dx.doi.org/10.1016/j.jmb.2007.04.028 .,OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1101/gad.13.10.1251 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
21:4349 – 4356. http://dx.doi.org/ 10.1093/emboj/cdf431 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
344: 609 – 618. http://dx.doi.org/10.1016/j.jmb.2004.09.070 .,OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1093/nar/18.24.7243 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/ 10.1006/jmbi.1996.0479 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
253: 414 – 425. http://dx.doi.org/10.1006/jmbi.1995.0563 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1074/ jbc.M110.152264 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/ 10.1093/emboj/16.12.3666 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1074/jbc.M108456200 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1016/j.jmb.2006.02.022 .,OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1073/ pnas.89.23.11264 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
8:619. http://dx.doi.org/ 10.1038/msb.2012.50 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
Nature 452:840 – 845. http://dx.doi.org/ 10.1038/nature06847 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1128/ MMBR.00037-08 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
Nature 430:85– 88. http://dx.doi.org/10.1038/ nature02698 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1093/ nar/17.24.10295 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
"358: 614 – 633. http://dx.doi.org/10.1016/j.jmb.2006.02.019 .33.Lee SJ, Trostel A, Le P, Harinarayanan R, Fitzgerald PC, Adhya S. 2009.",OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1073/ pnas.0910586106 .,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1111/j.1365-2958.2004.04392.x .Selective Engineering of Signal Integration Logic May/June 2014 Volume 5 Issue 3 e01171-14®mbio.asm.org 7,Non-OADS,/arxiv_data1/oa_pdf/2a/80/mBio.01171-14.PMC4073488.pdf
http://dx.doi.org/10.1371/journal.pone.0033781 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1097/00007435 -198807000-00013 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
193:617– 624. http://dx.doi.org/10.1086/500149 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1086/505432 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
197:449 – 456. http://dx.doi.org/10.1086/525285 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/ 10.1128/IAI.00147-09 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1128/AAC.01321-09 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1016/j.trsl.2011.01.007 .,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.4110/in.2011.11.5.227 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1038/nri2708 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/ 10.1086/605443 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.4161/ rna.20018 .,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1073/ pnas.1117207108 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1128/IAI.00772-09 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1074/jbc.M109.013862 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1161/ CIRCULATIONAHA.111.087817 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
Tuberculosis (Edinb) 93:606 – 611. http://dx.doi.org/10.1016/j.tube.2013.08.006 .,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1073/ pnas.0901216106 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
Immunity 31:854 – 855. http://dx.doi.org/10.1016/ j.immuni.2009.11.004 .,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
179:4027– 4034. http://dx.doi.org/10.4049/jimmunol.179.6.4027 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
189:6222– 6235. http://dx.doi.org/10.1128/JB.00552-07 .Yeruva et al.,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1111/2049-632X.12121 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
80:612– 619. http://dx.doi.org/10.1128/IAI.06054-11 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
Genome Res.23:855– 866. http://dx.doi.org/10.1101/gr.150037.112 .,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1038/ nprot.2013.147 .,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1099/ mic.0.070029-0 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1128/IAI.00200-11 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1371/ journal.pntd.0002117 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
171: 6187– 6197. http://dx.doi.org/10.4049/ jimmunol.171.11.6187 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/ 10.1073/pnas.0610731104 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
"http://dx.doi.org/10.1038/ nature06205 .40.Barron AL, White HJ, Rank RG, Soloff BL, Moses EB.",OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
Dis.143:63– 66. http://dx.doi.org/10.1093/infdis/143.1.63 .,OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1093/nar/28.6.1397 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.4056/sigs.1223234 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1093/nar/30.11.2478 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1371/ journal.pone.0032911 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1186/gb-2009-10-3 -r25.,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1093/nar/gkt1181 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1186/gb-2010-11 -10-r106 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.1093/bioinformatics/ btp616 .,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
http://dx.doi.org/10.4049/jimmunol.1103060 .miRNA Expression in Chlamydial Genital Infection May/June 2014 Volume 5 Issue 3 e01241-14®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/05/5c/mBio.01241-14.PMC4073489.pdf
"The utilities of the HMMER suite version 3.1b1 (45) were compiled under Cygwin (version1.7.27; http://www.cygwin.com ), and hmmpress was used to convert the Pfam-A data ﬁles (version 27) (46) to binaries.",OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
The use of HMM-HMM proﬁle comparisons and comparisons to structured proteins contained in theProtein Data Bank (PDB; http://www.rcsb.org/pdb ) (49) allowed the de- tection of remote homologs not detectable by sequence-sequence orsequence-proﬁle analyses.,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/ 10.1126/science.1110591 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1038/nature09944 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
Science 341: 1237439. http://dx.doi.org/10.1126/ science.1237439 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
"24:40 – 49. http://dx.doi.org/10.1016/j.cub.2013.10.077 .6.Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, Comstock LE.2001.",OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
69:4342– 4350. http://dx.doi.org/10.1128/ IAI.69.7.4342-4350.2001 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
186:6077– 6092. http://dx.doi.org/10.1128/JB.186.18.6077-6092.2004 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1038/nm.2015 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/ 10.1074/jbc.R109.022848 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1038/nrmicro2746 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1371/journal.pone.0035053 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/ 10.1016/0147-619X(79)90044-1 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
12:412– 416. http://dx.doi.org/10.1016/j.tim.2004.07.004 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
mBio 4(6):e00569- 13.http://dx.doi.org/10.1128/mBio.00569-13 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1038/nrmicro2382 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
61:845– 852. http://dx.doi.org/10.1093/ jac/dkn033 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
63:80 – 86. http://dx.doi.org/10.1093/jac/dkn437 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/ 10.1016/j.plasmid.2012.11.002 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1038/ hdy.2010.24 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1371/journal.pgen.1000439 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1111/j.1600 -0765.2004.00719.x .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1111/ j.1574-6976.2008.00159.x .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/ 10.1016/j.chom.2013.11.008 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1093/nar/gkl217 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1002/prot.22499 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1074/jbc.M111.301630 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1074/jbc.M113.499772 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1128/ JB.01559-07 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1126/science.1106469 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1111/j.1574-6976.2011.00294.x .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1016/j.tig.2012.12.006 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1126/science.1243745 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1093/bioinformatics/ btm404 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
BMC Bioinformatics 11:119. http://dx.doi.org/10.1186/ 1471-2105-11-119 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1093/nar/gkt1244 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1093/ nar/gkr1065 .,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1093/nar/gks1243 .,Non-OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/10.1093/nar/28.1.235 .Coyne et al.,OADS,/arxiv_data1/oa_pdf/34/b2/mBio.01305-14.PMC4073490.pdf
http://dx.doi.org/ 10.1038/nrmicro1493 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1146/ annurev.biochem.72.121801.161737 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
8:634 – 644. http://dx.doi.org/10.1038/nrmicro2405 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
187: 6324 – 6332. http://dx.doi.org/10.1128/JB.187.18.6324 -6332.2005 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1159/000077866 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1038/355182a0 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1146/annurev.micro.57.030502.090832 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1016/j.tim.2008.10.002 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1073/pnas.0700266104 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1038/emboj.2011.186 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1128/AEM.68.1.316-325.2002 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1099/ijs.0.02195-0 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.4056/sigs.671209 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.4056/sigs.2456004 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1016/ j.anaerobe.2013.06.004 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1038/nrmicro3016 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/IAI.01176-06 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
52:471– 484. http://dx.doi.org/10.1111/j.1365 -2958.2004.03988.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
15:456 – 461. http://dx.doi.org/10.1016/j.tim.2007.09.006 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/IAI.70.4.1984-1990.2002 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
Microbiol.65:389 – 410. http://dx.doi.org/10.1146/annurev-micro-090110-102908 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/MMBR.00035-10 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002602 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
16:428 – 435. http://dx.doi.org/10.1016/ j.tim.2008.07.002 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1007/978-1-60761-454-8_16 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1046/j.1365-2958.2003.03527.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002420 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/JB.01689-08 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
187: 4463– 4469. http://dx.doi.org/10.1128/JB.187.13.4463-4469.2005 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1016/j.chom.2009.08.003 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1038/ nmeth.1377 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1073/ pnas.0906627106 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/ JB.183.7.2384-2388.2001 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1007/s10142-011-0214-7 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
BMC Genomics 12:535. http://dx.doi.org/10.1186/1471-2164-12-535 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1016/j.tim.2005.02.008 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
3:128. http://dx.doi.org/10.1038/ msb4100166 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1046/ j.1365-2958.2001.02376.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
14:883– 893. http://dx.doi.org/10.1111/j.1365-2958.1994.tb01324.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1097/ MOG.0b013e3282f1dcb1 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1038/ nprot.2011.417 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/IAI.00109-10 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
74:4694 – 4707. http://dx.doi.org/10.1128/IAI.00210-06 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
193:6411– 6412. http://dx.doi.org/10.1128/JB.06084-11 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/ AEM.01844-07 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.4056/sigs.2094859 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1000362 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/IAI.01220-09 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2003.03954.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/JB.185.5.1624 -1633.2003 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1128/IAI.74.1.769-772.2006 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1016/ j.jmb.2008.09.036 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1046/j.1365 -2958.1998.00998.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
BMC Genomics 7:167. http://dx.doi.org/10.1186/1471-2164-7-167 .,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1038/nsmb833 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1128/IAI.01370-12 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1016/S0966-842X(03)00079-9 .69.,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1074/jbc.M300036200 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
65:76 – 89. http://dx.doi.org/10.1111/j.1365 -2958.2007.05770.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2010.07079.x .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1099/ mic.0.2007/007401-0 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1002/9780471729259.mc01e03s19 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/ 10.1128/IAI.01216-06 .,Non-OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
http://dx.doi.org/10.1126/science.1201476 .Epsilonproteobacterium Flagellar System Components May/June 2014 Volume 5 Issue 3 e01349-14®mbio.asm.org 13,OADS,/arxiv_data1/oa_pdf/4e/d7/mBio.01349-14.PMC4073491.pdf
"Data used in comparative analysis were down- loaded from the NCBI database ( http://www.ncbi.nlm.nih.gov/genome/ genomes/815 ), including complete genome sequences and annotation of K. pneumoniae isolates HS11286 (CP003200) (29), JM45 (CP006656), ATCC BAA-2146 (CP006659) (30), Kp13 (CP003999) (8),NJST258_1(CP006923) (7), and NJST258_2 (CP006918) (7).",OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
4:48.http://dx.doi.org/10.3389/ fmicb.2013.00048 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1128/CMR.05035-11 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1128/AAC.00126-09 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
111:4988 – 4993. http://dx.doi.org/ 10.1073/pnas.1321364111 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
BMC Genomics 15:54. http://dx.doi.org/10.1186/ 1471-2164-15-S2-P54 .,OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1128/AAC.02673-14 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1093/jac/dkq431 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1111/j.1469-0691.2012.03805.x .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.3201/eid1609.091389 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
187: 8312– 8321. http://dx.doi.org/10.1128/ JB.187.24.8312-8321.2005 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
Science 327: 469 – 474. http://dx.doi.org/10.1126/science.1182395 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1093/infdis/ jis605 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/ 10.1073/pnas.0803654105 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
207:439 – 449. http://dx.doi.org/10.1093/infdis/jis703 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1093/nar/gkt1373 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1093/jac/ dkq133 .,OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
68:84 – 88. http://dx.doi.org/ 10.1093/jac/dks356 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1128/JB.00043-12 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1016/j.ijantimicag.2012.05.019 .,OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
BMCGenomics 12:402. http://dx.doi.org/10.1186/1471-2164-12-402 .,OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/ 10.1093/nar/gkq1255 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1371/journal.pone.0011147 .,Non-OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1093/molbev/ msr121 .Chen et al.,OADS,/arxiv_data1/oa_pdf/17/1a/mBio.01355-14.PMC4073492.pdf
http://dx.doi.org/10.1007/s003740050424 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1016/j.soilbio.2009.12.003 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1073/ pnas.0810193105 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1016/j.scitotenv.2012.11.050 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1007/BF01343848 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1046/j.1365 -2389.2002.00461.x .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1111/gcb.12461 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1021/ic061843f .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1159/000091562 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1111/j.1574-6941.2010.00856.x .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1016/0168-6496(96)00008-6 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1111/j.1574-6941.2010.00873.x .15.,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1007/BF02277359 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1099/mic.0.054148-0 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1111/j.1462-2920.2007.01557.x .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
Microbiol.3:370. http://dx.doi.org/10.3389/fmicb.2012.00370 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1111/1462-2920.12142 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1038/ismej.2012.125 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1128/ JB.187.6.1992-2001.2005 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1007/BF01138070 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1128/ AEM.00810-12 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1128/AEM.06435-11 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1128/JB.00871-12 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1073/ pnas.1211238109 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1016/B978-0-12-387046 -9.00002-5 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1111/j.1365-2486.2010.02334.x .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1111/ j.1472-4669.2011.00276.x .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.2134/ jeq1997.2651399x .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.2136/sssaj2004.1600 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1007/s00374-010-0484-6 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1080/09064710500218845 .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1016/ j.soilbio.2007.03.006 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.3354/ame014113 .44.,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1111/ j.1574-6941.2008.00495.x .,Non-OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1016/j.mimet.2007.08.011 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1016/0076-6879(87)52005-5 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1128/AEM.66.12.5488-5491.2000 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/10.1016/j.femsec.2004.04.011 .,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
http://dx.doi.org/ 10.1007/BF02529967 .Liu et al.,OADS,/arxiv_data1/oa_pdf/4b/01/mBio.01383-14.PMC4073493.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/ea/sfs114.PMC4073520.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/c9/sfs180.PMC4073521.pdf
:  Glaucoma trial design review Perspectives in Clinical Research | July-September 2014 | Vol 5 | Issue 3 109(http://www.ncbi.nlm.nih.gov/pubmed) published between  1990 and 2012.,Non-OADS,/arxiv_data1/oa_pdf/08/42/PCR-5-108.PMC4073546.pdf
"2007 [27]Inﬂ uence of collection method on side  effects adverse event incidence of reportedA speci ﬁ c ophthalmic symptom query more often elicits  a positive response than a general query IOP=Intraocular pressure, Graefes=Graefes arch clin exp ophthalmol Table 2: De ﬁ nitions of pharmaceutical phases of  development Trial De ﬁ nition Preclinical In vitro or  in vivo pharmacology and toxicology testing  of experimental drugs - that occurs before trials in humans may be conducted Phase I Initial human study to determine the metabolism and  pharmacologic, safety, dosing, and initial ef ﬁ cacy; may  include healthy participants and/or patients Phase II Short-term clinical studies to evaluate the effectiveness,  safety, and dosing of the drug in patients with the target disease  Phase III Expanded trials intended to gather additional  information to evaluate the overall bene ﬁ t-risk  relationship of the drug and provide adequate basis for regulatory approval Phase IV Postmarketing studies to delineate additional information  including the drug’s risks, bene ﬁ ts, and optimal use Deﬁ nitions amended from ClinicalTrials.gov (http://clinicaltrials.gov/ct2/info/ glossary) a partial explanation of  Gehr’s ﬁ nding.",Non-OADS,/arxiv_data1/oa_pdf/08/42/PCR-5-108.PMC4073546.pdf
Management:  https://www.surveymonkey.com/s/SAS_India_managment_needvswant_survey.,Non-OADS,/arxiv_data1/oa_pdf/40/44/PCR-5-125.PMC4073549.pdf
Programmer: https://www.surveymonkey.com/s/SAS_India_programmer_needvswant_survey.,OADS,/arxiv_data1/oa_pdf/40/44/PCR-5-125.PMC4073549.pdf
Perspectives in Clinical Research | July-September 2014 | Vol 5 | Issue 3 139Indian Regulatory Update: Jan-May 2014  http://www.cdsco.nic.in/writereaddata/uploaded_ for_website__1_FINAL2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ec/08/PCR-5-139.PMC4073552.pdf
"REVISED CHECKLIST FOR SERIOUS  ADVERSE EVENTS SUBMISSION • Central drugs standard control organization has issued  revised checklist for submission of  SAEs • It gives many new requirements like submission of   signed informed consent form, IB, protocol along with every submission of  death case • It now requires unblinded data to be submitted for  every death case • Complete checklist is available at the following URL: http://cdsco.nic.in/writereaddata/procedure%20for%20prescreening%20and%20checklist%20_ﬁ nal%20on%2022-04-2014.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ec/08/PCR-5-139.PMC4073552.pdf
"CENTRAL DRUGS STANDARD CONTROL  ORGANIZATION RELEASED GUIDANCE FOR AUDIO-VISUAL RECORDING OF INFORMED CONSENT PROCESS • Central drugs standard control organization (CDSCO)  has issued a guidance document for audio-visual recording of  informed consent process • Guidance document has details about procedure,  quality, storage and archival • Details of  the order can be read at the following URL: http://www.cdsco.nic.in/writereaddata/Guidance_for_AV%20Recording_09.January.",OADS,/arxiv_data1/oa_pdf/ec/08/PCR-5-139.PMC4073552.pdf
Suvarnapathaki: Regulatory update 140 Perspectives in Clinical Research | July-September 2014 | Vol 5 | Issue 3 • The draft rules have been published for information  of  all persons likely to be affected by these rules inviting comments from such persons within 45 days of  publication of  rules • Draft can be accessed from the following URL: http://www.cdsco.nic.in/writereaddata/1Draft%20 Rules%20on%20compensation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ec/08/PCR-5-139.PMC4073552.pdf
Available from: http://www.mapi-trust.,Non-OADS,/arxiv_data1/oa_pdf/50/33/JFCM-21-100.PMC4073557.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/50/33/JFCM-21-100.PMC4073557.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ec/cb/JFCM-21-107.PMC4073558.pdf
Available from: http://www.who.int/ whr/2006/whr06_en.pdf.,OADS,/arxiv_data1/oa_pdf/1a/92/JFCM-21-112.PMC4073559.pdf
Available from: http://www.nrhm‑mis.nic.in/UI/RHS/ RHS%202011/RHS%202011%20Webpage.htm.,Non-OADS,/arxiv_data1/oa_pdf/1a/92/JFCM-21-112.PMC4073559.pdf
Available from: http://www.who.int/health‑servicesdelivery/ human/workforce/papers/HR.pdf.,OADS,/arxiv_data1/oa_pdf/1a/92/JFCM-21-112.PMC4073559.pdf
Available from:  http://www.joe.org/joe/1995october/rb1.php.,Non-OADS,/arxiv_data1/oa_pdf/1a/92/JFCM-21-112.PMC4073559.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/1a/92/JFCM-21-112.PMC4073559.pdf
Available  from: http://www.whoint.org/ncd_report_full_en.pdf.,OADS,/arxiv_data1/oa_pdf/c6/48/JFCM-21-130.PMC4073562.pdf
Available from: http://www.who.int/chp/ steps/manual/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/c6/48/JFCM-21-130.PMC4073562.pdf
Available from:  http://www.whoindia.org/LinkFiles/NMH_Resources_National_ CVD_database-Final_Report.pdf.,OADS,/arxiv_data1/oa_pdf/c6/48/JFCM-21-130.PMC4073562.pdf
"Belfast: Department  of Health, Social Services and Public Safety Castle Buildings;  2003. http://www.dhsspsni.gov.uk/breaking_bad_news.pdf [Last  accessed on 2014 Jun] 4.",Non-OADS,/arxiv_data1/oa_pdf/bd/c0/JFCM-21-85.PMC4073565.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/bd/c0/JFCM-21-85.PMC4073565.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/bd/c0/JFCM-21-85.PMC4073565.pdf
Available from: http://www.who.int/hia/evidence/doh/ en/.,OADS,/arxiv_data1/oa_pdf/16/1d/JFCM-21-93.PMC4073566.pdf
Available from: http://www.world-sepsis-day.org/.,Non-OADS,/arxiv_data1/oa_pdf/54/6e/ATM-9-134.PMC4073568.pdf
Available from: http://www.world-sepsis- day.org.,Non-OADS,/arxiv_data1/oa_pdf/54/6e/ATM-9-134.PMC4073568.pdf
"Available from:  http://www.IHI.org, last accessed April 13, 2014.24.",Non-OADS,/arxiv_data1/oa_pdf/54/6e/ATM-9-134.PMC4073568.pdf
"Available from: http://www.ihi.org/knowledge/ Pages/ImprovementStories/WhatIsaBundle.aspx,   Last accessed April 13, 2014.",OADS,/arxiv_data1/oa_pdf/54/6e/ATM-9-134.PMC4073568.pdf
"Available from: http://www.ihi.org/offerings/IHIOpenSchool/ resources/Assets/Tools%20-%20BecomingaMoralAgent_ d2295c23-ade1-4cd9-8d55-8cab672cc151/Becoming_a_moral_ agent.doc, Last accessed April, 13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/54/6e/ATM-9-134.PMC4073568.pdf
Available from:  http://www.sf-36.org/tools/sf36.shtml [Last cited on 2013 May 31].,Non-OADS,/arxiv_data1/oa_pdf/b2/ae/ATM-9-144.PMC4073570.pdf
"Available from: http://www.who.int/tobacco [Last accessed on 2013, Oct 25].",Non-OADS,/arxiv_data1/oa_pdf/39/96/ATM-9-173.PMC4073576.pdf
"Available from: http://www.who.int/tobacco/communication/events/wntd/2006 [Last accessed on 2013, November 15].",Non-OADS,/arxiv_data1/oa_pdf/39/96/ATM-9-173.PMC4073576.pdf
"Available from: http://www.cdc.gov/tobacco/global/gyts/questionnaire.htm [Last accessed on 2013, September 10].",Non-OADS,/arxiv_data1/oa_pdf/39/96/ATM-9-173.PMC4073576.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/27/TODENTJ-8-109.PMC4073587.pdf
Contents lists available at ScienceDirect NeuroImage journal homepage: www.elsevier.com/locate/ynimg http://dx.doi.org/10.1016/j.neuroimage.2013.12.026 1053-8119©2014TheAuthors.PublishedbyElsevierInc.Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
"87, 527 –570 (URL: http://scholar.google.com/scholar?hl=en&btnG=Search&q= intitle:Uber+das+Elektrenkephalogramm+des+Menschen.#0 ).",Non-OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
2006.11.012 (URL: http://www.ncbi.nlm.nih.gov/pubmed/17196835 ).,OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
http://dx.doi.org/10.1073/pnas.1112685108 (URL: http://www.,OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.09.048 (URL: http://www.ncbi.nlm.nih.gov/pubmed/17997111 ).,OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.11.011 (URL: http://www.ncbi.nlm.nih.gov/pubmed/23165323 ).,OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.09.053 (URL: http://www.,OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
"16, 139 –158 (URL: http://www.ncbi.nlm.nih.gov/pubmed/15162912 ).",Non-OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
"48, 760 – 771. http://dx.doi.org/10.1109/10.930901 (URL: http://www.ncbi.nlm.nih.gov/pubmed/11442288 ).",OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
http://dx.doi.org/10.1109/10.623056 (URL: http://www.ncbi.nlm.nih.gov/pubmed/9282479 ).,OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
"Methods 25, 249–271.http://dx.doi.org/10.1006/meth.2001.1238 (URL: http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/05/b2/main.PMC4073650.pdf
Contents lists available at ScienceDirect NeuroImage journal homepage: www.elsevier.com/locate/ynimg http://dx.doi.org/10.1016/j.neuroimage.2013.12.009 1053-8119©2013TheAuthors.PublishedbyElsevierInc.Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/main.PMC4073651.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/a9/jiu087.PMC4073785.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/df/ce-9-071.PMC4073912.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCore Evidence 2014:9 71–80Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  71REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S5060 7Clinical utility of treprostinil in the treatment   of pulmonary arterial hypertension:   an evidence-based review Mitchell S Buckley1 Andrew J Berry1 Nadine H Kazem2 Shardool A Patel3 Paul A Librodo4 1Department of Pharmacy, Banner  Good Samaritan Medical Center,   Phoenix, AZ, USA;  2Department of   Pharmacy, St Joseph’s Hospital and  Medical Center, Phoenix, AZ, USA;   3Department of Pharmacy, Banner  Estrella Medical Center, Phoenix,    AZ, USA;  4Department of Pharmacy,   San Francisco vA Medical Center,    San Francisco, CA, USA Correspondence: Mitchell S Buckley   Clinical Pharmacy Specialist, Banner   Good Samaritan Medical Center,   Department of Pharmacy,    1111 E McDowell Rd, Phoenix,   AZ 85006, USA   Tel +1 602 839 3095  Fax +1 602 839 6734  Email m itchell.buckley@bannerhealth.",Non-OADS,/arxiv_data1/oa_pdf/32/df/ce-9-071.PMC4073912.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/32/df/ce-9-071.PMC4073912.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/df/ce-9-071.PMC4073912.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2014:6 311–318ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  311ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S6407 7Cost of opioid intravenous patient-controlled  analgesia: results from a hospital database analysis  and literature assessment Pamela Palmer1 Xiang Ji2 Jennifer stephens2 1acelRx Pharmaceuticals, inc.,   Redwood City, C a, 2Pharmerit  international, Bethesda, MD, Usa Correspondence: Pamela Palmer   acelRx Pharmaceuticals, inc.,   351 galveston Dr, Redwood City,   Ca 94063, Usa   Tel +1 650 216 3504  Fax +1 650 216 6500  Email ppalmer@acelrx.co mBackground:  Intravenous patient-controlled analgesia (PCA) equipment and opioid cost  analyses on specific procedures are lacking.",Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
"Available from: http://www.ismp.org/Newsletters/ acutecare/articles/20070222.as p. Accessed January  27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
"Available from: http://hcmatters.com/2012/04/premier- perspectives-database-comparative-effectiveness-research-cer- validated/#sthash.WPix7UW0.dpu f. Accessed May  1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
Available from: http://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
Available from: http://www.bls.gov/cpi /.,Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
"Available from: http://www.aami.org/infusionsummit/ AAMI_FDA_Summit_Report.pd f. Accessed January  27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
Available from: http://www.ecfr.gov/cgi-bin/text- idx?rgn=div5&node=21:9.0.1.1.,OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
Available  from: http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;j sessionid =36082DD5A67E4B69D165AC547A95748C?year =2013&i ndex =17&absnum =5065.,OADS,/arxiv_data1/oa_pdf/8a/16/ceor-6-311.PMC4073913.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/96/ccid-7-191.PMC4073914.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 191–199Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  191OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/CCID.S6309 3Do you know where your fillers go?",Non-OADS,/arxiv_data1/oa_pdf/14/96/ccid-7-191.PMC4073914.pdf
Available from: http://histology-slides-database.blogspot.de/2010/10/ human-lip-histology-slides_29.htm l. Lahore: King Edward Medical  University Lahore;  2013.,Non-OADS,/arxiv_data1/oa_pdf/14/96/ccid-7-191.PMC4073914.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/14/96/ccid-7-191.PMC4073914.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/96/ccid-7-191.PMC4073914.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/a6/cmar-6-279.PMC4073973.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 279–289Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  279Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CMAR.S6497 9Update on benefit of immunotherapy   and targeted therapy in melanoma:   the changing landscape Neeharika Srivastava David McDermott Department of Hematology/Oncology,   Beth Israel Deaconess Medical Center,   Boston, MA, USA Correspondence: David McDermott   Department of Hematology/Oncology,  Beth Israel Deaconess Medical Center,   375 Longwood Ave, MASCO  428,  Boston, MA  02215, USA   Tel +1 617 632 9270  Fax +1 617 632 9260  email dmcdermo@bidmc.harvard.ed uAbstract:  Malignant melanoma is on the rise.",Non-OADS,/arxiv_data1/oa_pdf/bc/a6/cmar-6-279.PMC4073973.pdf
"Available from: http://www.fda.gov/Safety/ MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ ucm249770.ht m. Accessed February  21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/bc/a6/cmar-6-279.PMC4073973.pdf
Available from: http://www.businesswire.,Non-OADS,/arxiv_data1/oa_pdf/bc/a6/cmar-6-279.PMC4073973.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bc/a6/cmar-6-279.PMC4073973.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/a6/cmar-6-279.PMC4073973.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/9f/cia-9-963.PMC4073974.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 963–968Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  963OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6423 5Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Hu et al Running head recto: Transradial coronary procedure DOI: http://dx.doi.org/10.2147/CIA.S64235 hongyu hu Qiang Fu Wei Chen Dezhao Wang Xu hua Buxing Chen Department of Cardiology, Beijing  Tiantan hospital, Capital Medical  University, Beijing, People’s republic  of China Correspondence: Buxing Chen   Department of Cardiology, Beijing Tiantan  hospital, Capital Medical University,   no 6 Tiantanxili, Dongcheng District,  Beijing, People’s republic of China   Tel +86 106 709 6572   Fax +86 106 709 6572   email chbux@126.co mA prospective randomized comparison   of left and right radial approach for percutaneous  coronary angiography in Asian populations Background:  The efficacy of coronary angiography may be different in the right radial approach   (RRA ) and the left radial approach  (LRA ) due to more common vascular tortuosity in the  RRA.",Non-OADS,/arxiv_data1/oa_pdf/4e/9f/cia-9-963.PMC4073974.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/4e/9f/cia-9-963.PMC4073974.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/4e/9f/cia-9-963.PMC4073974.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0e/f8/idr-7-167.PMC4073975.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 167–176Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  167RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S4882 0Horizontal gene transfer in the human   gastrointestinal tract: potential spread   of antibiotic resistance genes Jennifer R Huddleston Biology Department, Abilene  Christian University, Abilene, TX, USA Correspondence: Jennifer R Huddleston   Biology Department, Abilene Christian  University, ACU Box  27868, Abilene,   TX 79699, USA   Tel +1 325 674 2010  Fax +1 325 674 2009  email jennifer.huddleston@acu.ed uAbstract:  Bacterial infections are becoming increasingly difficult to treat due to widespread  antibiotic resistance among pathogens.",Non-OADS,/arxiv_data1/oa_pdf/0e/f8/idr-7-167.PMC4073975.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/0e/f8/idr-7-167.PMC4073975.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/f8/idr-7-167.PMC4073975.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/1b/ijn-9-3013.PMC4073976.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3013–3026International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3013OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6226 0Magnetic field enhanced convective diffusion  of iron oxide nanoparticles in an osmotically  disrupted cell culture model of the blood–brain  barrier Zhizhi Sun1 Matthew Worden2 Yaroslav Wroczynskyj3 Vinith Yathindranath4 Johan van Lierop3 T orsten hegmann1,2,4,5 Donald W Miller1 1Department of Pharmacology and  Therapeutics, University of Manitoba,   Winnipeg, Manitoba, Canada;   2Department of Chemistry and  Biochemistry, Kent State University,   Kent, OH, USA; 3Department of  Physics and Astronomy, 4Department  of Chemistry, University of Manitoba,   Winnipeg, Manitoba, Canada;   5Chemical Physics Interdisciplinary  Program, liquid crystal Institute,    Kent State University, Kent, OH, USAPurpose:  The present study examines the use of an external magnetic field in combination  with the disruption of tight junctions to enhance the permeability of iron oxide nanoparticles  (IONPs) across an in vitro model of the blood–brain barrier (BBB).",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/ijn-9-3013.PMC4073976.pdf
"The brain capillary endothelial layer is morphologically distinct compared  with other vascular beds because it lacks fenestrations, has reduced pinocytic activ - ity, and contains complex tight junctions.2 In addition to the restricted paracellular  diffusion of solutes, the expression of P-glycoprotein, multidrug-resistance protein,  breast cancer-resistance protein, and various other drug efflux transporters in brain  microvessel endothelial cells limit the transcellular diffusion of a wide variety of sol - utes and drugs.3–6 Although it is generally accepted that large molecules have limited   BBB permeability, smaller molecules also face restricted BBB permeability, with Correspondence: Donald W Miller Department of Pharmacology and  Therapeutics, 753 McDermot Avenue,  University of Manitoba, Winnipeg,  Manitoba R3E 0T6, Canada  T el +1 204 789 3278 Fax +1 204 789 3932 email donald.miller@med.umanitoba.c a T orsten hegmann Liquid Crystal Institute, Kent State  University, 1425 University Esplanade,  Kent, OH 44242-0001, USA  T el +1 330 672 7770 Fax +1 330 672 2796 email thegmann@kent.ed uJournal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Sun et al Running head recto: Magnetic nanoparticle permeability across the BBB DOI: http://dx.doi.org/10.2147/IJN.S62260",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/ijn-9-3013.PMC4073976.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/ijn-9-3013.PMC4073976.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3026sun et al Figure S4 Picture of a dispersion of N-(trimethoxysilylpropyl)ethylenediaminetri- acetate-iron oxide nanoparticles in water.Nanoparticle characterization Successful coating of the iron oxide nanoparticles with  N-(trimethoxysilylpropyl)ethylenediaminetriacetate (EDT)- silane was demonstrated first with Fourier transform infrared  spectroscopy, using a Nicolet Magna-IR Spectrometer 550  (Thermo Fisher Scientific, Waltham, MA, USA).",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/ijn-9-3013.PMC4073976.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/76/ijwh-6-623.PMC4074023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 623–629International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  623RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJWH.S4359 1Embolization of uterine fibroids from the point   of view of the gynecologist: pros and cons Michal Mara Kristyna Kubinova Department of Obstetrics and  Gynecology, General Faculty Hospital  and First Medical Faculty of Charles  University, Prague, Czech Republic Correspondence: Michal Mara   Department of Obstetrics and   Gynecology, General Faculty Hospital,   Apolinarska  18, Prague  2, Czech Republic   Tel +42 07 2396 8944  Fax +42 02 2496 7474  email michal@drmara.c zAbstract:  Uterine artery embolization (UAE) is a minimally invasive procedure with large  symptomatic potential in treatment of women with uterine leiomyomas.",Non-OADS,/arxiv_data1/oa_pdf/55/76/ijwh-6-623.PMC4074023.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/55/76/ijwh-6-623.PMC4074023.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/76/ijwh-6-623.PMC4074023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 249–258Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  249PersPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S5947 3Principles to guide sustainable implementation  of extended-scope-of-practice physiotherapy  workforce redesign initiatives in Australia:  stakeholder perspectives, barriers, supports,   and incentives Joanne Morris1 Karen Grimmer2 Lisa Gilmore1 chandima Perera3 Gordon Waddington4 Greg Kyle4 Bryan Ashman5 Karen Murphy6 1the Physiotherapy Department,   the canberra Hospital , Act  Health, canberra, A ct, Australia;   2international centre for Allied  Health evidence, University of south  Australia, Adelaide, sA, Australia;   3Department of rheumatology, the  canberra Hospital, canberra, A ct,   Australia; 4the Faculty of Health,   University of canberra , canberra,   Act, Australia; 5Department of  surgical services, the canberra  Hospital, canberra, A ct, Australia;   6Office of Allied Health Advisor, A ct  Health, canberra, A ct, Australia correspondence: Joanne Morris   Physiotherapy Department, canberra  Hospital, Level 1, Building 3, Yamba Dr,  Garran, Act, 2605, Australia   email jo.morris@act.gov.a uAbstract:  Sustainable implementation of new workforce redesign initiatives requires strategies  that minimize barriers and optimize supports.",Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
"Available from: http://www.physiotherapy.asn.au/ DocumentsFolder/ Advocacy_Position_Scope_of_Practice_2009.pd f, 2009.",Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
Available from: http://ec.europa.eu/social/main.js p?catId=706&langId =en&intPageId =205.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
Available from: http://www.accc.gov.au/system/files/Repor t to  ACCC – AMWAC Orthopaedic Surgery Workforce in Australia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
Available from: http://books.nap.edu/openbook.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
"Available from http://www.physiotherapyboard.gov.au/Codes- Guidelines/Code-of-conduct.asp x. Accessed February 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
Available from: http://www.physiotherapyboard.gov.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
"Available from: http://www.optometryboard.gov.au/documents/ default.aspx?record =WD10%2F158&dbid =AP&chksum =uA2c3Oie3 cwpQqUMXLHfKg%3D%3 D. Accessed October 7, 2013.",OADS,/arxiv_data1/oa_pdf/29/6c/jmdh-7-249.PMC4074174.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/imcrj-7-111.PMC4074175.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 111–115International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  111Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/ 10.2147/IMCRJ.S6485 5a case of anxiety associated with miliary  tuberculosis Fahad D alosaimi1 Feras a alkharboush2 Maram H altuwariqi1 1Department of p sychiatry, King saud  University, Riyadh, Kingdom of saudi  arabia; 2College of Medicine, King  saud University, Riyadh, Kingdom of  saudi arabia Correspondence: Fahad D alosaimi   psychiatry Dept #  55, King Khalid   University Hospital, po Box  7805,   Riyadh  11472, Kingdom of saudi arabia   tel +966 1467 1226;   Mob +966 503 441 370  Fax +966 1467 2571  email dr.fahad.alosaimi@gmail.co mAbstract:  Miliary tuberculosis (TB) is a serious infection with various presentations that can  perplex even the most experienced clinicians.",Non-OADS,/arxiv_data1/oa_pdf/b3/0c/imcrj-7-111.PMC4074175.pdf
Available from: http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/imcrj-7-111.PMC4074175.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/b3/0c/imcrj-7-111.PMC4074175.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/imcrj-7-111.PMC4074175.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/02/67/ppa-8-883.PMC4074176.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2014:8 883–891Patient Preference and Adherence Evaluation and improvement of doctor–patient  communication competence for emergency  neurosurgeons: a standardized family model Xi Wu1 Zhinong Wang2 Bo Hong1 Shengjuan Shen3 Yan Guo4 Qinghai Huang1 Jianmin Liu1 1Department of Neurosurgery,   Changhai Hospital, Shanghai, People’s  Republic of China; 2Department   of Surgical Education, Changhai  Hospital, Changzheng Hospital,   Shanghai, People’s Republic   of China; 3Department of Medical  Education, The Second Military  Medical University, Shanghai, People’s  Republic of China; 4Department of  Internal Medicine, Changhai Hospital,   Shanghai, People’s Republic of China Correspondence: Zhinong Wang   Department of Surgical Education,  Changhai Hospital, 168 Changhai Rd,  Shanghai 200433, People’s Republic  of China; Changzheng Hospital, 419  Fengyang Rd, Shanghai 200003, People’s  Republic of China   Tel +86 21 8187 3333   Fax +86 21 8187 3333   Email wangzn_smmu@sina.co m    Jianmin Liu   Department of Neurosurgery, Changhai  Hospital, 168 Changhai Rd, Shanghai  200433, People’s Republic of China   Tel +86 21 8187 3451   Fax +86 21 8187 3451   Email liu118@vip.163.co mAbstract:  Disease treatments have been significantly influenced by the communications between  patients, their families, and doctors the lack of which may lead to malpractice allegations  and complaints.",Non-OADS,/arxiv_data1/oa_pdf/02/67/ppa-8-883.PMC4074176.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/02/67/ppa-8-883.PMC4074176.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/02/67/ppa-8-883.PMC4074176.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/c4/ott-7-1123.PMC4074177.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1123–1127OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1123Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5979 5Combination therapy with brentuximab vedotin  and cisplatin/cytarabine in a patient with primarily  refractory anaplastic lymphoma kinase positive  anaplastic large cell lymphoma simon Heidegger1 ambros J Beer2 eva Geissinger3 andreas rosenwald3 Christian peschel1 Ingo ringshausen1 Ulrich Keller1 1III Medical Department,  2Nuclear  Medicine Department, Technische  Universität München, Munich,   Germany;  3Institute of pathology,   University of Würzburg, Würzburg,   Germany Correspondence: simon Heidegger;  Ulrich Keller   III Medical Department, Technische  Universität München, Ismaninger   str 22, 81675 Munich, Germany   Tel +49 89 4140 4111  Fax +49 89 4140 4879  email simon.heidegger@lrz.tum.d e;   ulrich.keller@lrz.tum.d eAbstract:  Anaplastic large cell lymphoma (ALCL) is a common subtype of the heterogeneous  group of peripheral T-cell lymphomas, which is characterized by large pleomorphic cells with  strong expression of CD30.",Non-OADS,/arxiv_data1/oa_pdf/34/c4/ott-7-1123.PMC4074177.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/34/c4/ott-7-1123.PMC4074177.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/c4/ott-7-1123.PMC4074177.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/72/ndt-10-1133.PMC4074178.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1133–1139Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1133OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6377 6association of dopamine D1 receptor gene  polymorphism with schizophrenia: a meta-analysis Yuqing Pan Jun Yao Baojie Wang institute of Forensic Medicine, china  Medical University, shenyang,    People’s republic of chinaAbstract:  To date, the role of dopamine D1 receptor  (DRD1 ) polymorphism in schizophrenia  remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/87/72/ndt-10-1133.PMC4074178.pdf
"Linkage associa - tion between DRD1  and schizophrenia has been reported in Chinese,8 American,9 and  Portuguese populations.10 Increasing evidence indicates that the polymorphism in the 5 ′  untranslated region of DRD1  is associated with the mediation of the therapeutic response  to antipsychotics,11 Moreover, present studies12–14 show that deficits in the DRD1  transmis - sion are associated with the cognitive and negative symptoms of schizophrenia and that  there is a significant decrease in DRD1  expression in the basal ganglia of schizophrenic  patients.15 In contrast, some studies have reported that there was no genetic association correspondence: Baojie Wang institute of Forensic Medicine, china  Medical University, No 92 North second  road, heping District, shenyang, 110001,  People’s republic of china email wangbj77@163.co mJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Pan et al Running head recto: Dopamine D1 receptor gene polymorphism and schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S63776",Non-OADS,/arxiv_data1/oa_pdf/87/72/ndt-10-1133.PMC4074178.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/87/72/ndt-10-1133.PMC4074178.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1139Dopamine D1 receptor gene polymorphism and schizophrenia  11.,Non-OADS,/arxiv_data1/oa_pdf/87/72/ndt-10-1133.PMC4074178.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/a7/sar-5-053.PMC4074179.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 53–62Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  53ORiginAl ReSeARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S6188 5examining the relationship between ethnicity and  the use of drug-related services: an ethnographic  study of nepali drug users in hong Kong Wai-Man Tang Anthropology Department,    The chinese University of   hong Kong, hong Kong correspondence: Wai-Man Tang   Room  407, humanities Building,   new Asia college, The chinese  University of hong Kong, Shatin,   nT, hong Kong   Tel 852 9327 4034  Fax 852 2603 5218  email wyman19@gmail.co mAbstract:  A recent survey has shown that Nepali drug users in Hong Kong tend to have a  low rate of usage of day-care and residential rehabilitation services, but a high rate of usage of  methadone services.",Non-OADS,/arxiv_data1/oa_pdf/5c/a7/sar-5-053.PMC4074179.pdf
Available from: http://www.nd.gov.hk/en/statistics_list.htm /.,OADS,/arxiv_data1/oa_pdf/5c/a7/sar-5-053.PMC4074179.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/5c/a7/sar-5-053.PMC4074179.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/a7/sar-5-053.PMC4074179.pdf
"Available from: http://www.cwin.org.np/resources/ cwin-publications/occasional-publication s. Accessed August 6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/5c/a7/sar-5-053.PMC4074179.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/ca/mder-7-219.PMC4074180.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 219–224Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  219ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S6344 9Investigation of biofilm formation on a charged   intravenous catheter relative to that on a similar   but uncharged catheter guy a Richards1,2 adrian J Brink3 Ross Mcintosh4 helen c steel5,6 Riana cockeran5,6 1Department of critical care,   charlotte Maxeke Johannesburg   academic hospital,  2Faculty of   health sciences, University of the   Witwatersrand, Johannesburg,    south africa;  3Department of   clinical Microbiology, ampath   national laboratory services,    Milpark hospital, Johannesburg,    south africa;  4nano-scale Transport   Physics laboratory, school of Physics,    University of the Witwatersrand,    Johannesburg, south africa;    5Medical Research council Unit   for inflammation and immunity,    Department of immunology,    University of Pretoria, Pretoria,    south africa;  6national health   laboratory service, Pretoria,    south africa correspondence: guy a Richards   Department of Medicine, Wits Medical   school,  7 York Road, Parktown  2195,   Johannesburg, south africa   Tel +27 11 488  3654  Fax +27 11 488 4675  Email guy.richards@wits.ac.z aAbstract:  Catheter-related blood stream infections increase morbidity, mortality, and costs.",Non-OADS,/arxiv_data1/oa_pdf/d2/ca/mder-7-219.PMC4074180.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/d2/ca/mder-7-219.PMC4074180.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/imcrj-7-103.PMC4074181.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2014:7 103–109International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  103Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/ 10.2147/IMCRJ.S6329 618F-fluorodeoxyglucose positron emission  tomography might be useful for diagnosis   of hepatic amyloidosis Akinobu Tawada1 tatsuo Kanda1 Takashi Oide2 T oshio Tsuyuguchi1 Fumio Imazeki1,3 Yukio Nakatani2 osamu Y okosuka1 1Department of Gastroenterology,   2Department of Diagnostic Pathology,   Chiba University Hospital, Chuo-ku,   Chiba, Japan;  3Safety and Health  Organization, Chiba University,   Inage-ku, Chiba, Japan Correspondence: tatsuo Kanda   Department of Gastroenterology, Chiba  University Hospital,  1-8-1 Inohana,  Chuo-ku, Chiba  260-8670, Japan   tel +81 43 226 2086  Fax +81 43 226 2088  email kandat-cib@umin.ac.j pAbstract:  We report on a woman with hepatic involvement of primary systemic (immunoglobulin  light chain, AL) amyloidosis.",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/imcrj-7-103.PMC4074181.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/imcrj-7-103.PMC4074181.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/imcrj-7-103.PMC4074181.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/b0/ndt-10-1125.PMC4074182.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1125–1131Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1125OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6140 9Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Ascher-Svanum et al Running head recto: Functioning with long-acting olanzapine injection DOI: http://dx.doi.org/10.2147/NDT.S61409 haya ascher-svanum1 Diego Novick2,3 Josep Maria haro4 Jordan Bertsch4 David McDonnell1 holland Detke1 1eli lilly and company, indianapolis,   iN, Usa; 2eli lilly and company,   Windlesham, surrey, UK;   3Departament de Psiquiatria,   Universitat autonoma de Barcelona,   spain; 4Parc sanitari sant Joan de Déu,   centro de investigación Biomédica  en red en el Área de salud Mental,   Universitat de Barcelona, Barcelona,   spain correspondence: haya ascher-svanum   lilly corporate center, Dc 2246, eli lilly  and company, indianapolis, iN 46285, Usa   T el +1 317 277 8713   Fax +1 317 276 7100   email ascher-svanum_haya@lilly.co mlong-term functional improvements in the 2-year  treatment of schizophrenia outpatients with  olanzapine long-acting injection Background:  Little is known about the long-term changes in the functioning of schizophrenia  patients receiving maintenance therapy with olanzapine long-acting injection (LAI), and whether  observed changes differ from those seen with oral olanzapine.",Non-OADS,/arxiv_data1/oa_pdf/c0/b0/ndt-10-1125.PMC4074182.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c0/b0/ndt-10-1125.PMC4074182.pdf
"Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1131Functioning with long-acting olanzapine injection  28. de Jong JT, Komproe IH.",Non-OADS,/arxiv_data1/oa_pdf/c0/b0/ndt-10-1125.PMC4074182.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/55/mder-7-225.PMC4074183.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 225–230Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  225ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S6322 0association between dentures and the rate   of falls in dementia sima ataollahi Eshkoor1 T engku aizan hamid1 siti sa’adiah hassan nudin2 chan Y oke Mun1 1institute of gerontology, Universiti  Putra Malaysia, serdang,  2institute for  Behavioral Research, Kuala lumpur,   Malaysia correspondence: Tengku aizan hamid   institute of gerontology,   Universiti Putra Malaysia, serdang,   selangor  43400, Malaysia   Email aizan@upm.edu.m yBackground:  Poor oral health, chronic diseases, functional decline, and low cognitive ability  can increase the risk of falls in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/98/55/mder-7-225.PMC4074183.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/98/55/mder-7-225.PMC4074183.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/ott-7-1135.PMC4074184.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1135–1141OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1135Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S6256 1Clinical analysis of  13 males with primary  choriocarcinoma and review of the literature Fang Jiang1 Yang Xiang1 Feng-Zhi Feng1 T ong ren1 Zhu-Mei Cui2 Xi-run Wan1 1Department of Obstetrics and  Gynecology, Peking Union Medical  College Hospital, Peking Union  Medical College, Chinese academy  of Medical sciences, Beijing, People’s  republic of China;  2Department  of Obstetrics and Gynecology, the  affiliated Hospital of the Medical  College, Qingdao University, Qingdao,  People’s republic of China Correspondence: Xi-run Wan   Department of Obstetrics and  Gynecology, Peking Union Medical  College Hospital, Peking Union Medical  College, Chinese academy of Medical  sciences, Number  1 shuaifuyuan  Wangfujing, DongCheng District,   Beijing  100730, People’s republic   of China   Tel +86 10 6915 4022  Fax +86 10 6915 4022  email wanxr@sina.co mObjective:  To analyze the management and prognosis of primary choriocarcinoma (PCC) in  male patients.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/ott-7-1135.PMC4074184.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/54/8e/ott-7-1135.PMC4074184.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/8e/ott-7-1135.PMC4074184.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/ijnrd-7-253.PMC4074185.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 253–260International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  253RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S4209 7Hereditary leiomyomatosis and renal cell  carcinoma Laura S Schmidt1,2 w Marston Linehan1 1Urologic Oncology Branch, Center  for Cancer Research, National Cancer  Institute, National Institutes of Health,  Bethesda, MD, USA;  2Basic Science  Program, Leidos Biomedical Research  Inc., Frederick National Laboratory for  Cancer Research, Frederick, MD, USA Correspondence: w Marston Linehan   Urologic Oncology Branch, Center   for Cancer Research, National Cancer   Institute – CRC Room  1w-5940,   9609 Medical Center Drive,   Bethesda, MD  20892, USA   Tel +1 301 496 6353  Fax +1 301 402 0922  email wml@nih.go vAbstract:  Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal-dom - inant hereditary syndrome, which is caused by germline mutations in the FH gene that encodes  the tricarboxylic acid cycle enzyme fumarate hydratase (FH).",Non-OADS,/arxiv_data1/oa_pdf/57/f8/ijnrd-7-253.PMC4074185.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/57/f8/ijnrd-7-253.PMC4074185.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/ijnrd-7-253.PMC4074185.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/28/vhrm-10-363.PMC4074186.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 363–366Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  363ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/VHRM.S4753 8The triple line pattern on carotid intima  media thickness imaging and its relationship to  cardiovascular risk factors in patients on lipid  lowering therapy Tania a singh1 T odd c Villines2 allen J Taylor3 1Division of cardiology, Medstar  georgetown University Hospital,  2Walter Reed national Military  Medical center, Bethesda, MD,   3georgetown University school of  Medicine, Washington, D c, Usa  correspondence: allen J Taylor   cardiology Division, georgetown  University Hospital, 3800 Reservoir Rd  nW, Washington, Dc 20007, Usa   email allen.taylor@gunet.georgetown.ed uBackground:  Carotid intima media thickness (CIMT) infrequently identifies a triple line   pattern (TLP) in the visualization of the internal elastic lamina.",Non-OADS,/arxiv_data1/oa_pdf/62/28/vhrm-10-363.PMC4074186.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/62/28/vhrm-10-363.PMC4074186.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/28/vhrm-10-363.PMC4074186.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/6d/tcrm-10-467.PMC4074187.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 467–474Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  467Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S4016 1Role of the latest endovascular technology   in the treatment of intermittent claudication Shigeo ichihashi Kimihiko Kichikawa Department of Radiology,    Nara Medical University,    Kashihara, Nara, Japan Correspondence: Shigeo ichihashi   Department of Radiology, Nara Medical   University,  840 Shijo-cho, Kashihara,   Nara 634-8521, Japan   Tel +817 4429 8900  Fax +817 4424 1988  email shigeoichihashi@yahoo.co.j pAbstract:  Intermittent claudication is a serious symptom in patients with peripheral arterial  disease, and severely limits activities of daily living.",Non-OADS,/arxiv_data1/oa_pdf/51/6d/tcrm-10-467.PMC4074187.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/51/6d/tcrm-10-467.PMC4074187.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/6d/tcrm-10-467.PMC4074187.pdf
2013. http://www.nws.noaa.gov/ om/hazstats.shtml .,OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
NYC Vital Signs Investigation Report: Deaths associated with heat waves in 2006. http://www.nyc.gov/html/doh/downloads/ pdf/survey/survey-2006heatdeaths.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
New York: US EPA; 2006. http://www.epa.gov/hiri/about/pdf/EHEguide_ ﬁnal.pdf 13.,OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
http://www.nyc.gov/html/doh/downloads/pdf/epi/databrief24.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
"District public health of ﬁces: New York City’s commitment to healthier neighborhoods, 2013. http://www.nyc.gov/html/doh/ downloads/pdf/dpho/dpho-brochure.pdf 17.",Non-OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
2011. http://www.aapor.org/AM/Template.cfm?Section=Standard_De ﬁnitions2&Template=/CM/ ContentDisplay.cfm&ContentID=3156 18.,Non-OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
Epiquery: NYC Interactive Health Data System –Census 2010. http://nyc.gov/health/epiquery 19.,OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
"Toronto, Ontario: Toronto Public Health; 2011. http://www1.toronto.ca/static ﬁles/ city_of_toronto/toronto_public_hea lth/healthy_environment/heat_alert/ ﬁles/pdf/ background ﬁle-39469.pdf 26.",Non-OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
2007. http://www.nyc.gov/html/doh/html/data/survey.shtml .,OADS,/arxiv_data1/oa_pdf/68/ad/11524_2013_Article_9850.PMC4074319.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Mechanisms of memory defects after complex short stress PM Maras et al 822 Molecular Psychiatry (2014), 811 –822 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/89/4d/mp201412a.PMC4074447.pdf
"World Glaucoma Week: WGW (http://www.wgweek.net/) is recognized annually on the  second week of March (this year, March 9-15)  in order to create and maintain global awareness and initiative for glaucoma control.",Non-OADS,/arxiv_data1/oa_pdf/b0/5f/JOVR-09-003.PMC4074467.pdf
"Acknowledgment This research was supported in part by Hormoz  Chams Research Chair in Public Health  Ophthalmology, Allama Tabatabaei Award, National Elite Foundation (http://bmn.ir/).",Non-OADS,/arxiv_data1/oa_pdf/b0/5f/JOVR-09-003.PMC4074467.pdf
http://www.emro.who.int/iran/ProgrammeAreas-OphthalmicDiseases.htm.,Non-OADS,/arxiv_data1/oa_pdf/b0/5f/JOVR-09-003.PMC4074467.pdf
http://www.who.int/choice/costs/CER_levels/en.,Non-OADS,/arxiv_data1/oa_pdf/b0/5f/JOVR-09-003.PMC4074467.pdf
http://www.ocularresponseanalyzer.com/downloads.html.,Non-OADS,/arxiv_data1/oa_pdf/2b/59/JOVR-09-007.PMC4074468.pdf
http://www.nei.nih.gov/audacious/.,Non-OADS,/arxiv_data1/oa_pdf/58/46/JOVR-09-126.PMC4074488.pdf
URL http://data.worldbank.org/indicator 15.,Non-OADS,/arxiv_data1/oa_pdf/ef/ec/nihms585444.PMC4074506.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2014, 5: 24649 - http://dx.doi.org/10.3402/dfa.v5.24649 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/70/75/DFA-5-24649.PMC4074606.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2014, 5: 24649 - http://dx.doi.org/10.3402/dfa.v5.24649",Non-OADS,/arxiv_data1/oa_pdf/70/75/DFA-5-24649.PMC4074606.pdf
"(a) Intraoperative clinical picture before revision of the ﬁrst metatarsophalangeal joint arthrodesis in a diabetic patient, (b) intraoperative clinical picture after revision, and (c) postoperative anteroposterior radiograph demonstrating the double plate ﬁxation technique.Complications with first MTPJ arthrodesis and diabetes mellitus Citation: Diabetic Foot & Ankle 2014, 5: 24649 - http://dx.doi.org/10.3402/dfa.v5.24649 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/70/75/DFA-5-24649.PMC4074606.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2014, 5: 24649 - http://dx.doi.org/10.3402/dfa.v5.24649",Non-OADS,/arxiv_data1/oa_pdf/70/75/DFA-5-24649.PMC4074606.pdf
"Surg Sci 2013; 4: 263 /C17.Complications with first MTPJ arthrodesis and diabetes mellitus Citation: Diabetic Foot & Ankle 2014, 5: 24649 - http://dx.doi.org/10.3402/dfa.v5.24649 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/70/75/DFA-5-24649.PMC4074606.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.043075.113.,OADS,/arxiv_data1/oa_pdf/46/18/1103.PMC4074677.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/46/18/1103.PMC4074677.pdf
Available	 from:	 http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ ucm207506.htm.,Non-OADS,/arxiv_data1/oa_pdf/4c/fd/JBCP-5-27.PMC4074692.pdf
Available	 from:	http://clinicaltrials.gov/ show/NCT01195727.,Non-OADS,/arxiv_data1/oa_pdf/4c/fd/JBCP-5-27.PMC4074692.pdf
Available from: http://clinicaltrials.gov/show/NCT00496769.66.,Non-OADS,/arxiv_data1/oa_pdf/4c/fd/JBCP-5-27.PMC4074692.pdf
Available	 from:	http://www.ift.,Non-OADS,/arxiv_data1/oa_pdf/31/96/JBCP-5-34.PMC4074693.pdf
Available	 from:	 http://www.fda.gov/RegulatoryInformation/Legislation/FDCAct.,Non-OADS,/arxiv_data1/oa_pdf/31/96/JBCP-5-34.PMC4074693.pdf
Available	 from:	http://www.nigeria.unfpa.org/pdf/ayhdfFramework.pdf.,Non-OADS,/arxiv_data1/oa_pdf/31/96/JBCP-5-34.PMC4074693.pdf
Available	 from: http://www.apps.who.int/medicinedocs/documents/s19606en/ s19606en.pdf [Last accessed on 2012 Oct 6].,Non-OADS,/arxiv_data1/oa_pdf/b6/8f/JBCP-5-40.PMC4074694.pdf
Available	 from:	http://www.ihfwkolkata.,Non-OADS,/arxiv_data1/oa_pdf/b6/8f/JBCP-5-40.PMC4074694.pdf
Available	 from:	http://www.cdsco.,Non-OADS,/arxiv_data1/oa_pdf/b6/8f/JBCP-5-40.PMC4074694.pdf
Available from:  http://www.cdsco.nic.in/National%20List%20of%20Essential%20 Medicine‑%20final%20copy.pdf	[Last	accessed	on	2012	Oct	6].,Non-OADS,/arxiv_data1/oa_pdf/b6/8f/JBCP-5-40.PMC4074694.pdf
Available	 from:	http://www.cimsasia.com/.,Non-OADS,/arxiv_data1/oa_pdf/7e/c6/JBCP-5-44.PMC4074695.pdf
Available	 from:	 http://www.reference.medscape.com/drug‑interactionchecker.,Non-OADS,/arxiv_data1/oa_pdf/7e/c6/JBCP-5-44.PMC4074695.pdf
Available from: http://www.medicinenet.com/drug_interactions/ article.htm#what.,Non-OADS,/arxiv_data1/oa_pdf/7e/c6/JBCP-5-44.PMC4074695.pdf
Available	 from:	http://www.kidney.org/professionals/ kdoqi/guidelines_bp/guide_11.htm.,Non-OADS,/arxiv_data1/oa_pdf/e1/99/JBCP-5-56.PMC4074698.pdf
Abstract: http://www.uroweb.org/events/abstracts–online/?AID=37759.,Non-OADS,/arxiv_data1/oa_pdf/a1/74/CEJU-67-00330.PMC4074718.pdf
URL:	http://www.cancer.gov/cancertopics/factsheet/Risk/cellphones2.,Non-OADS,/arxiv_data1/oa_pdf/1b/bb/CEJU-67-E66.PMC4074729.pdf
URL: http://sundhedsstyrelsen.dk/da/nyheder/2011/maends-saedkvalitet-er-ikke-faldende 7.,OADS,/arxiv_data1/oa_pdf/1b/bb/CEJU-67-E66.PMC4074729.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b3/34/srep05487.PMC4074782.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5487 | DOI: 10.1038/srep05487 6",Non-OADS,/arxiv_data1/oa_pdf/b3/34/srep05487.PMC4074782.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/90/48/srep05494.PMC4074788.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5494 | DOI: 10.1038/srep05494 6",Non-OADS,/arxiv_data1/oa_pdf/90/48/srep05494.PMC4074788.pdf
http://seer.cancer.gov/statfacts/html/ovary.html Date of access: 06/02/2014.,Non-OADS,/arxiv_data1/oa_pdf/fe/8f/srep05500.PMC4074789.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: R.G.M.,Non-OADS,/arxiv_data1/oa_pdf/fe/8f/srep05500.PMC4074789.pdf
supervised the project.Additional information Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f6/f6/srep05492.PMC4074790.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5492 | DOI: 10.1038/srep05492 8",Non-OADS,/arxiv_data1/oa_pdf/f6/f6/srep05492.PMC4074790.pdf
"As the most common typeof liver cancer, the most affected people of HCC come from Asia and Africa, where high prevalence of hepatitis B and hepatitis C strongly leads to the development of chronic liver disease and HCC (http://emedicine.medscape.com/article/197319-overview).",Non-OADS,/arxiv_data1/oa_pdf/06/b9/srep05501.PMC4074792.pdf
"As the third most common cancer in the world, more thanhalf of the people who die of Colon cancer come from developed countries (http://en.wikipedia.org/wiki/Colonic_cancer).",Non-OADS,/arxiv_data1/oa_pdf/06/b9/srep05501.PMC4074792.pdf
"If the colon cancer is found early, the doctor can use surgery, radiation, and/or chemotherapy for effec-tive treatment (http://www.webmd.com/colorectal-cancer/default.",Non-OADS,/arxiv_data1/oa_pdf/06/b9/srep05501.PMC4074792.pdf
We downloaded the miRNAfunctional similarity scores from http://cmbi.bjmu.edu.cn/misim/ in January 2010 (see Supplementary table 7).,OADS,/arxiv_data1/oa_pdf/06/b9/srep05501.PMC4074792.pdf
"We can obtain the relationship between diseases from MeSHdatabase (http://www.ncbi.nlm.nih.gov/), which provided a strict system for disease classification.",OADS,/arxiv_data1/oa_pdf/06/b9/srep05501.PMC4074792.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/06/b9/srep05501.PMC4074792.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/8d/srep05488.PMC4074794.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5488 | DOI: 10.1038/srep05488 8",Non-OADS,/arxiv_data1/oa_pdf/6b/8d/srep05488.PMC4074794.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/8e/srep05451.PMC4074826.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5451 | DOI: 10.1038/srep05451 8",Non-OADS,/arxiv_data1/oa_pdf/a4/8e/srep05451.PMC4074826.pdf
"Krinner, S., Stadler, D., Meineke, J., Brantut, J.-P. & Esslinger, T. Direct observation of fragmentation in a disordered, strongly interacting Fermi gas.http://arxiv.org/abs/1311.5174.",OADS,/arxiv_data1/oa_pdf/23/db/srep05495.PMC4074827.pdf
http://arxiv.org/ abs/1201.1496.,Non-OADS,/arxiv_data1/oa_pdf/23/db/srep05495.PMC4074827.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/db/srep05495.PMC4074827.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5495 | DOI: 10.1038/srep05495 5",Non-OADS,/arxiv_data1/oa_pdf/23/db/srep05495.PMC4074827.pdf
and S.M.discussed the results and wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/be/srep05489.PMC4074835.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/f6/oajsm-5-129.PMC4074897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 129–136Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  129OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6334 5Efficacy of arthroscopically placed pain catheter  adjacent to the suprascapular nerve (continuous  arthroscopically assisted suprascapular nerve  block) following arthroscopic rotator-cuff repair Kotaro Yamakado Department of Orthopaedics,    Fukui General Hospital, Fukui, Japan correspondence: Kotaro Yamakado   Department of Orthopaedics,   Fukui General Hospital,  58-16-1 Egami,   Fukui  9108561, Japan   Tel +81 7 7659 1300  Fax +81 7 7659 2538  email yamakadok@gmail.co mBackground:  Rotator-cuff surgery is well recognized to be a painful procedure.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/oajsm-5-129.PMC4074897.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/70/f6/oajsm-5-129.PMC4074897.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/f6/oajsm-5-129.PMC4074897.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ba/e0/srep05458.PMC4074969.pdf
"http://www.dsam.dk/ﬂ  x/forsiden/nyheder/spis-mindre-salt/   [12]     http://www.sbu.se/2014_03   [13]      He   FJ ,  Marrero   NM ,  MacGregor   GA  .",Non-OADS,/arxiv_data1/oa_pdf/66/a6/pri-32-53.PMC4075016.pdf
E-mail: a.j.berendsen@umcg.nl     This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike Licen se  (http://creativecommons.org/licenses/by-nc-sa/3.0)  (Received   24   February   2014  ; accepted   13   May   2014  ),Non-OADS,/arxiv_data1/oa_pdf/70/24/pri-32-55.PMC4075017.pdf
[11]  Available at:   http://www.oncoline.nl/coloncarcinoom (accessed  26 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/70/24/pri-32-55.PMC4075017.pdf
Trial registration number   The RCT was indexed at http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/37/da/pri-32-67.PMC4075019.pdf
Available online [1]  at: http://www.forsakringskassan.se (accessed June 2013).,Non-OADS,/arxiv_data1/oa_pdf/37/da/pri-32-67.PMC4075019.pdf
E-mail: maarit.nevalainen@helsinki.ﬁ   This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike Licen se  (http://creativecommons.org/licenses/by-nc-sa/3.0)    (Received   7   June   2013  ; accepted   13   May   2014  ),Non-OADS,/arxiv_data1/oa_pdf/73/95/pri-32-84.PMC4075022.pdf
E-mail: a.koffeman@erasmusmc.nl     This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike Licen se  (http://creativecommons.org/licenses/by-nc-sa/3.0)  (Received   26   November   2013  ; accepted   13   May   2014  ),Non-OADS,/arxiv_data1/oa_pdf/36/be/pri-32-90.PMC4075023.pdf
Available at:   http://www.ema.europa.eu/docs/en_GB/docu- ment_library/Press_release/2010/01/WC500059088.pdf  (accessed 21 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/36/be/pri-32-90.PMC4075023.pdf
Available at:   http://www.whocc.no/ (accessed 21 Nov  2013).,Non-OADS,/arxiv_data1/oa_pdf/36/be/pri-32-90.PMC4075023.pdf
E-mail: karin.ranstad@ltblekinge.se     This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike Licen se  (http://creativecommons.org/licenses/by-nc-sa/3.0)  (Received   5   June   2013  ; accepted   20   May   2014  ),Non-OADS,/arxiv_data1/oa_pdf/0f/ee/pri-32-99.PMC4075024.pdf
Available at:   http://www.scb.se/Pages/SSD/SSD_ SelectVariables____340487.aspx?px_tableid    /H11005    ssd_ extern:BefolkningMedelAlder & rxid    /H11005     e79a06b8-0999-4fc2- b4e2-a14b8a9b3b3b (accessed 8 April 2013).,OADS,/arxiv_data1/oa_pdf/0f/ee/pri-32-99.PMC4075024.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/0f/ncomms4262.PMC4075037.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Perea, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/8a/0f/ncomms4262.PMC4075037.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4262 12 NATURE COMMUNICATIONS | 5:3262 | DOI: 10.1038/ncomms4262 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/8a/0f/ncomms4262.PMC4075037.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 191–196Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  191PErsPEctivEsopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/AMEP .S6098 6Establishing a clinical pharmacology fellowship  program for physicians, pharmacists,   and pharmacologists: a newly accredited  interdisciplinary training program   at the Ohio state University Joseph P Kitzmiller1,4 Mitch A Phelps2 Marjorie v Neidecker3 Glen Apseloff4 1center for Pharmacogenomics,  colleges of Medicine and of  Engineering, the Ohio state  University Medical center,   2colleges of Pharmacy and Medicine,  Pharmacoanalytic shared resources  Laboratory, the Ohio state  University,  3colleges of Medicine,  Nursing, and Pharmacy, the Ohio  state University,  4Department of  Pharmacology, the Ohio state  University college of Medicine,   columbus, OH, UsA correspondence: Joseph P Kitzmiller   center for Pharmacogenomics, colleges  of Medicine and of Engineering, the Ohio  state University Medical center, 5072B  Graves Hall, 333 West tenth Avenue,  columbus, OH 43210, UsA   tel +1 614 292 8438  Email joseph.kitzmiller@osumc.ed uAbstract:  Studying the effect of drugs on humans, clinical pharmacologists play an essential role  in many academic medical and research teams, within the pharmaceutical industry and as members  of government regulatory entities.",Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
"Advances in Medical Education and Practice 2014:5submit your manuscript | www.dovepress.co m Dove press Dove press 192Kitzmiller et al Table  1 clinical pharmacology fellowship training programs with ABcP-accreditation Program, location Year accreditation   granted by ABCPWebsite, program highlights Baylor college of Medicine   Houston, tX, UsA2003 https://www.bcm.edu/departments/medicine/sections-divisions-centers/hypertension-and- clinical-pharmacology/education/hypertension-and-clinical-pharmacology   •  research program focuses on regulation of vascular function in health and disease •  clinical rotations include clinical Pharmacology research and Diagnostic clinic,  Hypertension and clinical Pharmacology consultation service, and clinical Pharmacokinetics  core Laboratory at Baylor college of Medicine or texas children’s Hospital •  trainee, in conjunction with the faculty in one of several departments or internal  medicine divisions within the college, determines an area of interest children’s Mercy Hospitals   and clinics   Kansas city, MO, UsA2008 https://www.childrensmercy.org/clinPharmFellowship /  •  the only pediatric clinical pharmacology program accredited by the ABcP in the Us •  Opportunity to conduct research alongside pediatric subspecialist physicians and  biomedical scientists committed to the evaluation of pediatric pharmacotherapies •  New (2012) pediatric clinical research unit with state-of-the-art facilities for research   and clinical trials Dartmouth-Hitchcock   Medical center   Lebanon, NH, UsA2006 No external website, contact Lionel.Lewis@Dartmouth.edu   •  Extensive training in oncology drug development •  research strengths in pharmacokinetic and bioanalytic methodology •  Opportunity to participate on clinical Pharmacology and toxicology consult services indiana University,   school of Medicine   indianapolis, iN, UsA2003 http://medicine.iupui.edu/clinpharm/fellowshi p  •  Pediatric, obstetric, and general clinical pharmacology specializations •  research strengths in personalized medicine and pharmacogenetics for cancer, Hiv, and  cardiovascular disease •  seven NiH-funded fellowship positions the Ohio state University,   college of Medicine   columbus, OH, UsA2009 http://www.medicine.osu.edu/pharmacology/graduate-programs/pages/fellowship-programs.",Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
"aspx  •  Associated with the center of Pharmacogenomics, OsU college of Medicine •  instruction, clinical experience, and research are tailored to trainee’s experience and interests •  Master’s degree in Pharmacology incorporated into fellowship thomas Jefferson Medical college,  Department of Pharmacology and   Experimental therapeutics   Philadelphia, PA, UsA2006 http://www.jefferson.edu/jmc/departments/pharmacology/education/fellowship.htm l  •  training within a dedicated academic phase i unit •  training experience with a pharmaceutical company, with the editorial board of the  Annals of internal Medicine journal, and with the Us Food and Drug Administration •  Opportunity to concentrate in adult or pediatric clinical pharmacology Uniformed services University   of the Health sciences and   Walter reed Army institute   of research school of Medicine   silver spring, MD, UsA2004 http://wrair-www.army.mil/Otherservices_clinicalPharmacology.asp x  •  Available to Us Army active-duty PhDs/PharmDs and Us Army physicians who are board  eligible/certified in a primary specialty; civilians can be considered but must join the US  Army and successfully compete for their fellowship position  •  conduct laboratory, animal, and clinical research under the supervision of a mentor •  3 month rotation at the FDA University of california at Los  Angeles David Geffen school of  Medicine   Los Angeles, cA, UsA2005 http://icptp.k30.ucla.ed u  •  Broad, interdisciplinary, program focused on clinical pharmacology and experimental  therapeutics •  salary support provided through the National institute of General Medical sciences  (NiGMs) t32 clinical Pharmacology Postdoctoral training Program grant •  Emphasis is placed on conducting research in special populations, including women,  children, geriatrics, and members of ethnic minorities •  clinical research curriculum available as an auditing-only track, a  2 year certificate  program in clinical research, or a Master of science (Ms) degree in clinical research University of chicago,   Division of Biological   sciences   chicago, iL, UsA2002 http://ccpp.bsd.uchicago.ed u  •  clinical and basic research projects in pharmacogenomics, drug development, clinical  pharmacology, genetics of drug abuse, and clinical trial design •  core curriculum includes courses in Pharmacogenomics, Personalized Medicine,  Advanced clinical Pharmacology, and Patient-Oriented research •  Experience serving on the University’s Biological sciences Division institutional review Board,  Pharmacy and therapeutics committee, and clinical Pharmacology consultation service •  three training tracks: clinical therapeutics, clinical therapeutics in Oncology, and  clinical therapeutics in industry Abbreviations:  ABCP, American Board of Clinical Pharmacology; FDA, US Food and Drug Administration; HIV, human immunodeficiency virus; NIH, National Institutes  of Health; OSU, the Ohio State University.",Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
Available from: http://www.accp1.org/history_ objectives.,Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
Available from: http://cc.nih.gov/training/training/principles/info.,Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
Available from: http://www.acrpnet.org /.,Non-OADS,/arxiv_data1/oa_pdf/86/8f/amep-5-191.PMC4075108.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/08/cia-9-969.PMC4075232.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 969–977Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  969RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S5992 7Journal name: Clinical Interventions in Aging Journal Designation: Review Y ear: 2014 Volume: 9 Running head verso: Sterniczuk et al Running head recto: Sleep in critically ill older patients DOI: http://dx.doi.org/10.2147/CIA.S59927 Roxanne Sterniczuk1–3 Benjamin Rusak1,2 Kenneth Rockwood3 1Department of Psychology and  Neuroscience, Dalhousie University,   Halifax, NS, 2Department of  Psychiatry, Dalhousie University,   Queen elizabeth II Health Sciences  Centre, Halifax, NS, 3Division   of Geriatric Medicine, Department   of Medicine, Queen elizabeth II  Health Sciences Centre, Halifax,    NS, Canada Correspondence: Kenneth Rockwood   Queen elizabeth II Health Sciences  Centre, Division of Geriatric Medicine,  Suite 1421-5955 v eterans Memorial Lane,  Halifax, NS, B3H 2e1 Canada   T el +1 902 473 8687   Fax +1 902 473 1050   email kenneth.rockwood@dal.c aSleep disturbance in older   ICU patients Abstract:  Maintaining a stable and adequate sleeping pattern is associated with good health and  disease prevention.",Non-OADS,/arxiv_data1/oa_pdf/d3/08/cia-9-969.PMC4075232.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d3/08/cia-9-969.PMC4075232.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d3/08/cia-9-969.PMC4075232.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/e2/dmso-7-211.PMC4075233.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 211–223Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  211Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5078 9Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/cd/e2/dmso-7-211.PMC4075233.pdf
"Or use: http://dvpr.es/1fOA92 Kislet cell transplantation for the treatment of type 1  diabetes: recent advances and future challenges Anthony Bruni Boris Gala-Lopez Andrew R Pepper Nasser S Abualhassan AM James Shapiro Clinical islet Transplant Program and  Department of Surgery, University of  Alberta, edmonton, AB, Canada Correspondence: AM James Shapiro   Clinical islet Transplant Program,   University of Alberta,   2000 College Plaza, 8215 112th St,  edmonton, AB T6G 2C8, Canada   Tel +1 780 407 7330   Fax +1 780 407 8259   email amjs@islet.c aAbstract:  Islet transplantation is a well-established therapeutic treatment for a subset of  patients with complicated type I diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/cd/e2/dmso-7-211.PMC4075233.pdf
"Available  from https://web.emmes.com/study/isl/reports/01062012_7 thAnnual   Report.pd f. Accessed April 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/cd/e2/dmso-7-211.PMC4075233.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/cd/e2/dmso-7-211.PMC4075233.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/e2/dmso-7-211.PMC4075233.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 613–627International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  613OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5999 5long-term dynamics of death rates of emphysema,  asthma, and pneumonia and improving air quality Julia Kravchenko1 Igor akushevich2 amy P abernethy3 sheila holman4 William g ross Jr5 h Kim lyerly1,6 1Department of surgery,  2Center for  Population health and aging,  3Duke  Clinical research Institute, Duke  University Medical Center, Duke  University, Durham,  4Division of air  Quality, north Carolina Department  of environment and natural  resources, raleigh,  5nicholas school  of the environment,  6Department of  Pathology, Duke University Medical  Center, Duke University, Durham,    nC, Usa Correspondence: Julia Kravchenko   Department of surgery, DUMC  3850,  Duke University Medical Center, Duke  University, Durham, nC  27710, Usa   Tel +1 919 668 6809  Fax +1 919 681 7970  email julia.krauchanka@duke.ed uBackground:  The respiratory tract is a major target of exposure to air pollutants, and respiratory  diseases are associated with both short- and long-term exposures.",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
"seer.cancer.gov/popdata/download.htm l. Data on concentrations of PM2.5 (µg/m3), PM10 (µg/m3),  ozone (ppb), CO (ppb), NO2 (ppb), and SO2 (ppb) in the air  in 1993–2010 were obtained from the US Environmental  Protection Agency (EPA) ( http://www.epa.gov/ttn/airs/air - saqs/detaildata/downloadaqsdata.ht m).",OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
"Also, data on the prevalence of tobacco use for  1995–2010  were obtained from the Centers for Disease Control and   Prevention Behavioral Risk Factor Surveillance System  survey for age–groups  18–24,  25–34,  35–44,  45–54,  55–64,  and 65+ years ( http://www.cdc.gov/brfs s).",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
"*Toxic air pollutants are those pollutants known or suspected to cause cancer or other serious health effects, such as birth defects  or reproductive effects ( http://www.epa.gov/airtrends/aqtrnd95/tap.htm l).",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
"Available from: http://www.ncleg.net/EnactedLegislation/  SessionLawsCD/SessionLaws/2002SessionLaws.pd f. Accessed  April  30, 2014.",OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/4b/copd-9-613.PMC4075234.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/d1/copd-9-647.PMC4075235.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 647–656International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  647OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6205 3surveillance of chronic obstructive pulmonary   disease in high-risk individuals by using   regional lung cancer mass screening Yasuo sekine ryoko Yanagibori Kiminori suzuki sonomi sugiyama haruko Yamaji Michiko Ishibashi Takehiko Fujisawa Chiba Foundation for health  Promotion and Disease   Prevention, Chiba, Japan Correspondence: Takehiko Fujisawa   Chiba Foundation for health   Promotion and Disease Prevention,   32-14 shinminato, Mihama-ku,   Chiba 261-0002, Japan   Tel +81 43 246 0350   Fax +81 43 248 640   email ta-fujisawa@kenko-chiba.or.j pBackground and objective:  Patients with chronic obstructive pulmonary disease (COPD)  are at risk for lung cancer; the diseases have common etiologies, including cigarette smoking.",Non-OADS,/arxiv_data1/oa_pdf/9c/d1/copd-9-647.PMC4075235.pdf
Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2013_Feb20.pdf .,OADS,/arxiv_data1/oa_pdf/9c/d1/copd-9-647.PMC4075235.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9c/d1/copd-9-647.PMC4075235.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/d1/copd-9-647.PMC4075235.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/78/ca/cia-9-979.PMC4075236.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/78/ca/cia-9-979.PMC4075236.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/ca/cia-9-979.PMC4075236.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 979Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  979CorrIgendumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6768 7Journal name: Clinical Interventions in Aging Journal Designation: Corrigendum Y ear: 2014 Volume: 9 Running head verso: Milanovi ć et al Running head recto: Running head recto DOI: http://dx.doi.org/10.2147/CIA.S67687 Age-related decrease in physical activity and functional fitness   among elderly men and women [Corrigendum] Milanovic ´ Z, Pantelic ´ S, Trajkovic ´ N, et al.",Non-OADS,/arxiv_data1/oa_pdf/78/ca/cia-9-979.PMC4075236.pdf
"http://informahealthcare.com/csu ISSN: 1092-9088 (print), 1097-0150 (electronic) Comput Aided Surg, 2014; 19(1–3): 48–56 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d7/a0/CSU-19-048.PMC4075248.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d7/a0/CSU-19-048.PMC4075248.pdf
"http://informahealthcare.com/csu ISSN: 1092-9088 (print), 1097-0150 (electronic) Comput Aided Surg, 2014; 19(1–3): 13–19 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/de/68/CSU-19-013.PMC4075249.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/de/68/CSU-19-013.PMC4075249.pdf
See Supplementary Materials (available online at http://informahealthcare.com/doi/abs/10.3109/01677063.2014.883389) for details regarding sample fractionation and liquid chromatography – tandem mass spectrometry (LC-MS/MS) analysis.,Non-OADS,/arxiv_data1/oa_pdf/48/1a/NEG-28-136.PMC4075250.pdf
"We performed mixing error corrections, a label incorporation correction (as detailed in Supplementary Figure 1 available online at http://informahealthcare.com/doi/abs/10.3109/01677063.2014.883389), and a logic test of the data.",OADS,/arxiv_data1/oa_pdf/48/1a/NEG-28-136.PMC4075250.pdf
"In total, as shown in Table 1, 15 labeled-pairs  were determined to be of interest either (Ox-B ratio  /H11022  Ox-B /H11001    ORA ratio  /H11022  ORA ratio) or (ORA ratio   /H11022  x-B /H11001    ORA ratio  /H11022  Ox-B ratio) based on the data treat- ment and criteria described in Materials and Methods and Supplementary Figure 1 available online at http://informahealthcare.com/doi/abs/10.3109/01677063.2014.883389 (false-positive rate estimated to range from 16% to 38% with  n     /H11005    500 simulations and 2 – 20 degrees of free- dom as described in Materials and Methods).",Non-OADS,/arxiv_data1/oa_pdf/48/1a/NEG-28-136.PMC4075250.pdf
Supplementary Figures 2 and 3 available online at http://informahealthcare.com/doi/abs/10.3109/01677063.2014.883389 contain the MS/MS spectra for peptides presented in Table 1.,OADS,/arxiv_data1/oa_pdf/48/1a/NEG-28-136.PMC4075250.pdf
"Additionally, many of these proteins have been associated with neurological disorders (ATP1B1, CNP, LDHA, MBP, PPIA, SNCA, SYT1, TUBA1A, YWHAH) (Supplementary Table 1 available online at http://informahealthcare.com/doi/abs/10.3109/01677063.2014.883389).",Non-OADS,/arxiv_data1/oa_pdf/48/1a/NEG-28-136.PMC4075250.pdf
"http://informahealthcare.com/csu ISSN: 1092-9088 (print), 1097-0150 (electronic) Comput Aided Surg, 2014; 19(1–3): 20–28 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f5/74/CSU-19-020.PMC4075251.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f5/74/CSU-19-020.PMC4075251.pdf
"http://informahealthcare.com/csu ISSN: 1092-9088 (print), 1097-0150 (electronic) Comput Aided Surg, 2014; 19(1–3): 29–33 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/18/83/CSU-19-029.PMC4075256.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/18/83/CSU-19-029.PMC4075256.pdf
"http://informahealthcare.com/csu ISSN: 1092-9088 (print), 1097-0150 (electronic) Comput Aided Surg, 2014; 19(1–3): 1–12 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/75/02/CSU-19-001.PMC4075257.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/75/02/CSU-19-001.PMC4075257.pdf
"http://informahealthcare.com/csu ISSN: 1092-9088 (print), 1097-0150 (electronic) Comput Aided Surg, 2014; 19(1–3): 34–47 !2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/7d/ad/CSU-19-034.PMC4075258.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7d/ad/CSU-19-034.PMC4075258.pdf
TheAlignRT commercial optical system (http://www.visionrt.- com) uses a structured light pattern projected on the subject’s surface.,Non-OADS,/arxiv_data1/oa_pdf/7d/ad/CSU-19-034.PMC4075258.pdf
The absoluteaccuracy of this ToF camera is ±1 cm or ±1% (http://www.mesa-imaging.ch/swissranger4000.php).,Non-OADS,/arxiv_data1/oa_pdf/7d/ad/CSU-19-034.PMC4075258.pdf
Manufacturer’s website: http://www.pneumacare.com/Clinical-Data/respiratory/Case-Studies.aspx.,Non-OADS,/arxiv_data1/oa_pdf/7d/ad/CSU-19-034.PMC4075258.pdf
"http://e-jbm.org/   117Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:117-126 http://dx.doi.org/10.11005/jbm.2014.21.2.117 pISSN 2287-6375    eISSN 2287-7029 Can Dental Cone Beam Computed Tomography  Assess Bone Mineral Density?",Non-OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
Do-Gyoon Kim 118  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.117been widely used non-invasive device to assess bone  mass.,Non-OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
http://dx.doi.org/10.11005/jbm.2014.21.2.117  http://e-jbm.org/   119research purposes only.,Non-OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
Do-Gyoon Kim 120  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.117sorbs more energy resulting in a higher attenuation value.,Non-OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
"http://dx.doi.org/10.11005/jbm.2014.21.2.117  http://e-jbm.org/   121However, accuracy of the CBCT based HU measurement  still remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
Do-Gyoon Kim 122  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.117for the same material.,Non-OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
"http://dx.doi.org/10.11005/jbm.2014.21.2.117  http://e-jbm.org/   123(Livewire®,[62] Institute of Computing, State University of  Campinas, Brazil[61] and ImageJ, National Institutes of  Health, Bethesda, Maryland, USA) (Fig.",OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
Do-Gyoon Kim 124  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.117bone histomorphometric data.,OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
http://dx.doi.org/10.11005/jbm.2014.21.2.117  http://e-jbm.org/   125metric comparison of trabecular structure of human ilium  between microcomputed tomography and conventional  histomorphometry.,OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
Do-Gyoon Kim 126  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.117treatment on human alveolar bone density distribution.,Non-OADS,/arxiv_data1/oa_pdf/e9/d7/jbm-21-117.PMC4075265.pdf
"http://e-jbm.org/   127Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:127-132 http://dx.doi.org/10.11005/jbm.2014.21.2.127 pISSN 2287-6375    eISSN 2287-7029 Genetics of Ossification of the Posterior  Longitudinal Ligament of the Spine: A Mini Review Shiro Ikegawa Laboratory of Bone and Joint Diseases, Center for Genomic Medicine, RIKEN, Tokyo, Japan Ossification of the posterior longitudinal ligament of the spine (OPLL) is a common dis - ease in aging populations and sometimes results in serious neurological problems due  to compression of the spinal cord and nerve roots.",Non-OADS,/arxiv_data1/oa_pdf/55/2e/jbm-21-127.PMC4075266.pdf
"Shiro Ikegawa 128  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.127phosphoprotein 1 ( DMP1 ) (MIM 600980), hypophospha - temic rickets, autosomal recessive 2 ( ARHR2 ) (MIM 613312)  or ectonucleotide pyrophosphatase/phosphodiesterase 1  (ENPP1 ) (MIM 173335) mutations.",OADS,/arxiv_data1/oa_pdf/55/2e/jbm-21-127.PMC4075266.pdf
"Genetics of OPLL http://dx.doi.org/10.11005/jbm.2014.21.2.127  http://e-jbm.org/   129suggestive linkage on 1p, 2p, 7q, 16q, and 20p.",OADS,/arxiv_data1/oa_pdf/55/2e/jbm-21-127.PMC4075266.pdf
Shiro Ikegawa 130  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.127paravertebral ligaments: a frequent complication of hypo - parathyroidism.,OADS,/arxiv_data1/oa_pdf/55/2e/jbm-21-127.PMC4075266.pdf
Genetics of OPLL http://dx.doi.org/10.11005/jbm.2014.21.2.127  http://e-jbm.org/   13128.,Non-OADS,/arxiv_data1/oa_pdf/55/2e/jbm-21-127.PMC4075266.pdf
"http://e-jbm.org/   133Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:133-142 http://dx.doi.org/10.11005/jbm.2014.21.2.133 pISSN 2287-6375 eISSN 2287-7029 Association of Arterial Stiffness and Osteoporosis in  Healthy Men Undergoing Screening Medical  Examination Nam Lee Kim, Ha Min Jang, Sul Ki Kim, Ki Dong Ko, In Cheol Hwang, Heuy Sun Suh Department of Family Medicine, Gachon University Gil Hospital, Incheon, Korea Background:  Association of arterial stiffness and osteoporosis has been previously re - ported in women.",Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
134  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.133between low bone density and peripheral vascular disease  was investigated with ankle-brachial index and there was  no correlation in men which differed to the results in wom - en.,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
Association of arterial stiffness and osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.133  http://e-jbm.org/   135BP: ≥130/85 mmHg.,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
136  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.133Table 2.,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
"Association of arterial stiffness and osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.133  http://e-jbm.org/   137significant correlation for diastolic BP (r =0.247, P=0.009; r  =0.250, P=0.008 [male]), (r =0.693, P<0.001; r =0.569, P<  0.001 [female]), and fasting blood glucose (r =0.201, P=0.035  [male], r =0.454, P=0.004 [female]).",Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
138  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.1334.,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
"Association of arterial stiffness and osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.133  http://e-jbm.org/   139articular areas, hence BMD reduction starts in spine and  after 70 years old age, not only spongy bone reduction starts  but also the reduction of cortical bone begins and leads to  the BMD reduction of coxal articulate.",Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
140  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.133and arteriosclerosis start to progress.,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
Association of arterial stiffness and osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.133  http://e-jbm.org/   14120.,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/jbm-21-133.PMC4075267.pdf
"http://e-jbm.org/   143Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:143-150 http://dx.doi.org/10.11005/jbm.2014.21.2.143 pISSN 2287-6375    eISSN 2287-7029 Physicians’ Attitudes to Contemporary Issues on  Osteoporosis Management in Korea  Yong-Chan Ha1, Young-Kyun Lee2, Yong-Taik Lim3, Sun-Mee Jang4, Chan Soo Shin5 1Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul;   2Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam;   3Department of Obstetrics and Gynecology, Yeouido St. Mary’s Hospital, The Catholic University of Korea, Seoul;   4College of Pharmacy, Gachon University, Incheon;   5Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Background:  In management of osteoporosis, several concerns here have been raised.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/jbm-21-143.PMC4075268.pdf
144  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.143agnosis of osteoporosis and the decision for treatment rely  primarily on the assessment of bone mineral density (BMD)  and on the inclusion of personal risk factors.,Non-OADS,/arxiv_data1/oa_pdf/8a/55/jbm-21-143.PMC4075268.pdf
"Physicians’ Attitudes to Contemporary Issues on Osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.143  http://e-jbm.org/   145RESULTS Of 1,282 members of KSBMR who were asked, 104 (8.1%)  returned fully completed questionnaires.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/jbm-21-143.PMC4075268.pdf
"146  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.143was not applicable to their practice (8/71, 11.3%).",Non-OADS,/arxiv_data1/oa_pdf/8a/55/jbm-21-143.PMC4075268.pdf
"Physicians’ Attitudes to Contemporary Issues on Osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.143  http://e-jbm.org/   147DISCUSSION In this study, we evaluated physicians’ attitude in several  contemporary issues on osteoporosis treatment and iden - tified the barriers to osteoporosis treatment in Korea, by  using e-mail survey system.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/jbm-21-143.PMC4075268.pdf
"148  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.143Fifth, several guideline for osteoporosis management in - clude calcium supplementation, because the full effect of  anti-osteoporosis drugs depends on the sufficient use of  calcium.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/jbm-21-143.PMC4075268.pdf
Physicians’ Attitudes to Contemporary Issues on Osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.143  http://e-jbm.org/   149national Society for Clinical Densitometry 2007 Adult Po - sition Development Conference and Official Positions.,Non-OADS,/arxiv_data1/oa_pdf/8a/55/jbm-21-143.PMC4075268.pdf
"http://e-jbm.org/   151Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:151-154 http://dx.doi.org/10.11005/jbm.2014.21.2.151 pISSN 2287-6375    eISSN 2287-7029 Hypertrophic Osteoarthropathy in Patient with  Crohn’s Disease: A Case Report Sung-Min Rhee1, Ki Jeong Park2, Yong-Chan Ha1  Departments of 1Orthopaedic Surgery, 2Radiology, Chung-Ang University College of Medicine, Seoul, Korea Numerous causes of hypertrophic osteoarthropathy (HOA) have been reported.",Non-OADS,/arxiv_data1/oa_pdf/bd/ac/jbm-21-151.PMC4075269.pdf
152  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.151CASE A 27-year-old man with hyperhidrosis on both his palm  and sole and digital clubbing presented with a 2-year his - tory of multiple joint pain.,Non-OADS,/arxiv_data1/oa_pdf/bd/ac/jbm-21-151.PMC4075269.pdf
The Secondary Hypertrophic Osteoarthropathy  http://dx.doi.org/10.11005/jbm.2014.21.2.151  http://e-jbm.org/   153DISCUSSION The patient presented with multiple joint pain and tubu - lar bone hypertrophic osteopathies.,Non-OADS,/arxiv_data1/oa_pdf/bd/ac/jbm-21-151.PMC4075269.pdf
154  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.151ter stage as a treatment of HOA.,Non-OADS,/arxiv_data1/oa_pdf/bd/ac/jbm-21-151.PMC4075269.pdf
"http://e-jbm.org/   155Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:155-160 http://dx.doi.org/10.11005/jbm.2014.21.2.155 pISSN 2287-6375    eISSN 2287-7029 Atypical Femoral Fracture Combined with  Osteonecrosis of Jaw During Osteoporosis  Treatment with Bisphosphonate Yougun Won1, Joon-Ryul Lim2, Young-Hwan Kim2, Hyung-keun Song3, Kyu Hyun Yang2 1Department of Orthopaedic Surgery, Konyang University College of Medicine, Daejeon;   2Department of Orthopaedic Surgery, Yonsei Univeristy College of Medicine, Seoul;   3Department of Orthopaedic Surgery, Aju University College of Medicine, Suwon, Korea Bisphosphonate, a potent anti-resorptive agent, is generally accepted as a safe, effective,  well tolerated treatment for postmenopausal osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/99/49/jbm-21-155.PMC4075270.pdf
156  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.155Alendronate (70 mg/week for 3 years) for 7 years.,Non-OADS,/arxiv_data1/oa_pdf/99/49/jbm-21-155.PMC4075270.pdf
Atypical Femoral Fracture and Osteonecrosis of Jaw Treatment with Bisphosphonate http://dx.doi.org/10.11005/jbm.2014.21.2.155  http://e-jbm.org/   157formed osteotomy at lateral cortex below the lag screw to  making a notch for sliding (Fig.,Non-OADS,/arxiv_data1/oa_pdf/99/49/jbm-21-155.PMC4075270.pdf
158  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.155DISCUSSION Bisphosphonate is the most widely prescribing agent for  treating osteoporosis.,Non-OADS,/arxiv_data1/oa_pdf/99/49/jbm-21-155.PMC4075270.pdf
Atypical Femoral Fracture and Osteonecrosis of Jaw Treatment with Bisphosphonate http://dx.doi.org/10.11005/jbm.2014.21.2.155  http://e-jbm.org/   1598.,Non-OADS,/arxiv_data1/oa_pdf/99/49/jbm-21-155.PMC4075270.pdf
" http://e-jbm.org/   161J Bone Metab 2014;21:161 http://dx.doi.org/10.11005/jbm.2014.21.2.161 pISSN 2287-6375    eISSN 2287-7029 Compression Fracture in Postpartum Osteoporosis Judith L. Gutowski IBCLC, RLC, Hannastown, United States1 3 5 McGrath Lane, Hannastown, USA Dear Editor, I read with interest your article titled, “Compression frac - ture in postpartum osteoporosis” .",Non-OADS,/arxiv_data1/oa_pdf/cb/42/jbm-21-161.PMC4075271.pdf
"http://e-jbm.org/   85Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:85-98 http://dx.doi.org/10.11005/jbm.2014.21.2.85 pISSN 2287-6375    eISSN 2287-7029 Pathobiology of Paget’s Disease of Bone Deborah L. Galson1, G. David Roodman2,3 1Department of Medicine/Hematology-Oncology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine,  Pittsburgh PA;   2Department of Medicine/Hematology-Oncology, Indiana University, Indianapolis IN;   3Veterans Administration Medical Center, Indianapolis, IN, USA.",Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
86  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.85that results in bony expansion and structural weakness of  the involved bone.,Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
Osteoclast and Osteoblast Activity in Paget’s Disease http://dx.doi.org/10.11005/jbm.2014.21.2.85  http://e-jbm.org/   87ial risk of Paget’s disease.,Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
"88  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.85OCL precursors from Paget’s patients carrying p62P392L were  hyper-responsive to 1,25-(OH) 2D3, expressed increased  TAF12 RNA polymerase II, TATA box binding protein (TBP)- associated factor, 20kDa (TAF12), a VDR coactivator, and  formed hyper-nucleated OCL  in vitro , whereas, the MVNP- negative OCL precursors from Paget’s patients carrying  p62P392L did none of these, although the patients had pag - etic lesions in vivo .",Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
"Osteoclast and Osteoblast Activity in Paget’s Disease http://dx.doi.org/10.11005/jbm.2014.21.2.85  http://e-jbm.org/   89pared to wildtype (WT) mice, no pagetic OCL or lesions  were detected  in vivo , and μqCT analysis of bones from  these mice did not reveal any significant differences be - tween p62 KI/TIL-6 and WT mice.",Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
"90  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.85TNF-α receptor TNFR1 signals, in part, via formation of a  complex that includes receptor-interacting protein 1 (RIP1)  binding to p62 via the p62 ZZ domain, which then leads to  recruitment of aPKCs to the p62 AID domain and down - stream signal activation.",Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
Osteoclast and Osteoblast Activity in Paget’s Disease http://dx.doi.org/10.11005/jbm.2014.21.2.85  http://e-jbm.org/   91mRNA levels are elevated in MVNP-expressing cells.,Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
92  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.85Expression of OCL fusion molecules in OCL  precursors OCL precursors from TRAP-MVNP mice and pagetic pa - tients expressing MVNP form OCL with increased nuclei  per OCL as a result of increased cell fusion of mononuclear  OCL precursors.,Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
"Osteoclast and Osteoblast Activity in Paget’s Disease http://dx.doi.org/10.11005/jbm.2014.21.2.85  http://e-jbm.org/   93Other bone formation factors that are elevated in Paget’s  include fibroblast growth factor 2 (FGF2), which was re - ported to be elevated in the serum of Paget’s patients and  increased by MVNP expression in OCL precursors.",Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
94  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.85of bone (author's transl).,Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
Osteoclast and Osteoblast Activity in Paget’s Disease http://dx.doi.org/10.11005/jbm.2014.21.2.85  http://e-jbm.org/   9532.,Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
96  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.8559.,Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
"Osteoclast and Osteoblast Activity in Paget’s Disease http://dx.doi.org/10.11005/jbm.2014.21.2.85  http://e-jbm.org/   97Annual Meeting; 2013 October 4-7; Baltimore, MD, USA.",Non-OADS,/arxiv_data1/oa_pdf/2b/ec/jbm-21-85.PMC4075272.pdf
"http://e-jbm.org/   99Copyright © 2014 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2014;21:99-116 http://dx.doi.org/10.11005/jbm.2014.21.2.99 pISSN 2287-6375    eISSN 2287-7029 Genome-wide Association Studies for Osteoporosis:  A 2013 Update Yong-Jun Liu1, Lei Zhang1,2, Christopher J. Papasian3, Hong-Wen Deng1,2 1Center for Bioinformatics and Genomics, Department of Biostatistics, School of Public Health and Tropical Medicine, Tulane University,      New Orleans, LA, USA   2Center of System Biomedical Sciences, University of Shanghai for Science and Technology, Shanghai, PR, China   3University of Missouri - Kansas City, School of Medicine, Kansas City, MO, USA In the past few years, the bone field has witnessed great advances in genome-wide as - sociation studies (GWASs) of osteoporosis, with a number of promising genes identified.",Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
100  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.99ses.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   101Table 1.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
102  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.99Table 1.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   103Table 1.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
104  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.99Table 1.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   10514q24.2 (rs227425, P=3.98x10-13, SPARC related modular  calcium binding 1 [SMOC1]) and 21q22.13 (rs170183,  P=4.15x10-9, claudin 14 [CLDN14]).",Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"106  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.99replication (n =1,022) identified one locus reaching ge - nome-wide significance (formin 2 [FMN2]/ gremlin 2, DAN  family BMP antagonist [GREM2], rs9287237, P=1.9x10-9).",OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   107Comparing the results of the two published GEFOS me - ta-analyses, it is interesting to note that several loci identi - fied in GEFOS-1 (e.g., corticotropin releasing hormone re - ceptor 1 [ CRHR1 ] and histone deacetylase 5 [ HDAC5 ]) were  not significant in GEFOS-2, despite the fact that the num - ber of samples of GEFOS-2 almost tripled the number in  GEFOS-1, and the majority of samples used in GEFOS-1  were included in GEFOS-2.",OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
108  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.99found to be significant in the two GEFOS meta-analyses.,OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   109of fracture at different sites is different in terms of age,  gender and ethnicity.",Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
110  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.994.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   111To address these critical questions, we performed a se - ries of theoretical analyses using simulation studies and  published our results elsewhere.",Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
112  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.99and related biological pathways has been reviewed else - where.,OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"The recent 1,000 Ge - nomes Project (http://www.1000genomes.org/) produced  a comprehensive catalog of human genomic variants, in  particular rare variants.",OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   113modification, may also contribute to our comprehensive  identification and understanding of cellular and molecular  mechanisms regulating bone metabolism.",Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
114  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2014.21.2.99e1003247.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
GWASs for osteoporosis http://dx.doi.org/10.11005/jbm.2014.21.2.99  http://e-jbm.org/   115213:246-51.,Non-OADS,/arxiv_data1/oa_pdf/58/a3/jbm-21-99.PMC4075273.pdf
"First published online March 18, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 265-272, http://dx.doi.org/10.1590/1414-431X20133418 ISSN 1414-431X Review www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/25/9d/1414-431X-bjmbr-47-04-00265.PMC4075289.pdf
"First published online March 21, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 273-278, http://dx.doi.org/10.1590/1414-431X20133356 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/1414-431X-bjmbr-47-04-00273.PMC4075290.pdf
"First published online March 18, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 279-286, http://dx.doi.org/10.1590/1414-431X20133539 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/8b/55/1414-431X-bjmbr-47-04-00279.PMC4075291.pdf
"First published online March 31, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 287-298, http://dx.doi.org/10.1590/1414-431X20143301 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/2f/45/1414-431X-bjmbr-47-04-00287.PMC4075292.pdf
"First published online March 31, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 299-306, http://dx.doi.org/10.1590/1414-431X20143368 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/56/be/1414-431X-bjmbr-47-04-00299.PMC4075293.pdf
"First published online March 18, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 307-315, http://dx.doi.org/10.1590/1414-431X20143437 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/c2/c6/1414-431X-bjmbr-47-04-00307.PMC4075294.pdf
"First published online April 7, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 316-320, http://dx.doi.org/10.1590/1414-431X20143001 ISSN 1414-431X Braz J Med Biol Res 47(4) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/1414-431X-bjmbr-47-04-00316.PMC4075295.pdf
The electronic version of this questionnaire can be accessed at http://www.each.usp.br/crono.,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/1414-431X-bjmbr-47-04-00316.PMC4075295.pdf
"First published online March 21, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 321-327, http://dx.doi.org/10.1590/1414-431X20143209 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/90/2b/1414-431X-bjmbr-47-04-00321.PMC4075296.pdf
"Brası ´lia: DENATRAN, 2008. http://www.denatran.gov.br/publicacoes/download/ctb.pdf.",Non-OADS,/arxiv_data1/oa_pdf/90/2b/1414-431X-bjmbr-47-04-00321.PMC4075296.pdf
http://www.icap.org/portals/0/download/all_pdfs/ICAP_Reports_English/report11.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/2b/1414-431X-bjmbr-47-04-00321.PMC4075296.pdf
"First published online March 21, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 328-333, http://dx.doi.org/10.1590/1414-431X20143472 ISSN 1414-431X Braz J Med Biol Res 47(4) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/fa/a5/1414-431X-bjmbr-47-04-00328.PMC4075297.pdf
"First published online March 21, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 334-339, http://dx.doi.org/10.1590/1414-431X20133249 ISSN 1414-431X Braz J Med Biol Res 47(4) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/e3/70/1414-431X-bjmbr-47-04-00334.PMC4075298.pdf
"First published online April 7, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 340-344, http://dx.doi.org/10.1590/1414-431X20133353 ISSN 1414-431X Short Communication Braz J Med Biol Res 47(4) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/db/77/1414-431X-bjmbr-47-04-00340.PMC4075299.pdf
"First published online March 31, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 345-348, http://dx.doi.org/10.1590/1414-431X20143468 ISSN 1414-431X Short Communication www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/a9/37/1414-431X-bjmbr-47-04-00345.PMC4075300.pdf
"First published online April 7, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(4): 349-354, http://dx.doi.org/10.1590/1414-431X20143606 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(4) 2014",Non-OADS,/arxiv_data1/oa_pdf/e1/41/1414-431X-bjmbr-47-04-00349.PMC4075301.pdf
"First published online April 16, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 355-360, http://dx.doi.org/10.1590/1414-431X20143714 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(5) 2014",Non-OADS,/arxiv_data1/oa_pdf/bb/47/1414-431X-bjmbr-47-05-00355.PMC4075302.pdf
"First published online April 11, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 361-368, http://dx.doi.org/10.1590/1414-431X20142937 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(5) 2014",Non-OADS,/arxiv_data1/oa_pdf/93/32/1414-431X-bjmbr-47-05-00361.PMC4075303.pdf
"The entire datasets (for miRNAs) described here are available from the Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) through the accession number GSE38599.",Non-OADS,/arxiv_data1/oa_pdf/93/32/1414-431X-bjmbr-47-05-00361.PMC4075303.pdf
"Hierarchical clustering was performed using the MeV software (v4.6, TIGR; http://www.tm4.org/mev.html).",OADS,/arxiv_data1/oa_pdf/93/32/1414-431X-bjmbr-47-05-00361.PMC4075303.pdf
"Bioinformatics analysis Potential targets of the identified miRNAs were analyzed using an online algorithmic prediction program, miRMap 2.0 (http://miRNAMap.mbc.nctu.edu.tw/), which collected the results from multiple miRNA target predic- tion programs and filtered them according to the following criteria: targets located in the 3 9-UTR region, seed length of at least 7 bp, and P ,0.05.",OADS,/arxiv_data1/oa_pdf/93/32/1414-431X-bjmbr-47-05-00361.PMC4075303.pdf
The predicted target genes were enriched using the KEGG orthology-based annotation system (KOBAS) (http://kobas.cbi.pku.edu.cn/ home.do).,OADS,/arxiv_data1/oa_pdf/93/32/1414-431X-bjmbr-47-05-00361.PMC4075303.pdf
"Material and Methods Gene expression profiles The Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/) is currently the largest Correspondence: W. Wang, Department of Gastroenterology, Fuzhou General Hospital of Nanjing Command, Fuzhou, 350025, China.",OADS,/arxiv_data1/oa_pdf/0c/ed/1414-431X-bjmbr-47-05-00369.PMC4075304.pdf
"First published online April 4, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 369-375, http://dx.doi.org/10.1590/1414-431X20143527 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(5) 2014",Non-OADS,/arxiv_data1/oa_pdf/0c/ed/1414-431X-bjmbr-47-05-00369.PMC4075304.pdf
"We down- loaded all the human signaling pathways from BioCarta (http://www.biocarta.com/genes/Cellsignaling.asp) (14), removed redundant information, and represented all proteins with their corresponding genes.",OADS,/arxiv_data1/oa_pdf/0c/ed/1414-431X-bjmbr-47-05-00369.PMC4075304.pdf
"First published online April 16, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 376-383, http://dx.doi.org/10.1590/1414-431X20143639 ISSN 1414-431X Braz J Med Biol Res 47(5) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/5c/0b/1414-431X-bjmbr-47-05-00376.PMC4075305.pdf
"First published online April 4, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 384-393, http://dx.doi.org/10.1590/1414-431X20143190 ISSN 1414-431X Braz J Med Biol Res 47(5) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/1c/a9/1414-431X-bjmbr-47-05-00384.PMC4075306.pdf
"First published online April 4, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 394-397, http://dx.doi.org/10.1590/1414-431X20143751 ISSN 1414-431X Braz J Med Biol Res 47(5) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/0f/67/1414-431X-bjmbr-47-05-00394.PMC4075307.pdf
"First published online April 11, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 398-402, http://dx.doi.org/10.1590/1414-431X20143697 ISSN 1414-431X Short Communication Braz J Med Biol Res 47(5) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/da/d4/1414-431X-bjmbr-47-05-00398.PMC4075308.pdf
Statistical analysis Statistical analysis was performed using the BIOESTAT 5.0 software (Brazil; http://www.mamiraua.org.br/pt-br/ downloads/programas/).,OADS,/arxiv_data1/oa_pdf/da/d4/1414-431X-bjmbr-47-05-00398.PMC4075308.pdf
"First published online April 4, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 403-410, http://dx.doi.org/10.1590/1414-431X20143443 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(5) 2014",Non-OADS,/arxiv_data1/oa_pdf/f0/0b/1414-431X-bjmbr-47-05-00403.PMC4075309.pdf
"First published online May 2, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 411-418, http://dx.doi.org/10.1590/1414-431X20143767 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(5) 2014",Non-OADS,/arxiv_data1/oa_pdf/72/00/1414-431X-bjmbr-47-05-00411.PMC4075310.pdf
"First published online April 4, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 419-425, http://dx.doi.org/10.1590/1414-431X20143629 ISSN 1414-431X www.bjournal.com.br Braz J Med Biol Res 47(5) 2014",Non-OADS,/arxiv_data1/oa_pdf/13/5f/1414-431X-bjmbr-47-05-00419.PMC4075311.pdf
http://www.ibge.gov.br/ home/estatistica/populacao/condicaodevida/pof/2008_2009_ analise_consumo/pofanalise_2008_2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/13/5f/1414-431X-bjmbr-47-05-00419.PMC4075311.pdf
"First published online April 16, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 426-431, http://dx.doi.org/10.1590/1414-431X20143370 ISSN 1414-431X Braz J Med Biol Res 47(5) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/99/86/1414-431X-bjmbr-47-05-00426.PMC4075312.pdf
"First published online April 16, 2014.Brazilian Journal of Medical and Biological Research (2014) 47(5): 432-437, http://dx.doi.org/10.1590/1414-431X20143628 ISSN 1414-431X Braz J Med Biol Res 47(5) 2014 www.bjournal.com.br",Non-OADS,/arxiv_data1/oa_pdf/a0/77/1414-431X-bjmbr-47-05-00432.PMC4075313.pdf
"Brian G.Forde* andMichael R.Roberts Address: Lancaster Environment Centre, Lancaster University, Bailrigg, Lancaster, LA1 4YQ, UK *Corresponding author: Brian G.Forde (b.g.forde@lancaster.ac.uk) F1000Prime Reports 2014, 6:37(doi:10.12703/P6-37) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/06/37 Abstract Plant glutamate receptor-like genes (GLRs)arehomologous tothegenes formammalian ionotropic glutamate receptors (iGluRs), after which they were named, butinthe16years since their existence wasfirstrevealed, progress inelucidating their biological role hasbeen disappointingly slow.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:37 http://f1000.com/prime/reports/b/06/37",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"At least in the case of AtGLR3.3 and perhaps other members of GLR clade 3, there is now strong evidence for a role in the innate immune response but what might Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:37 http://f1000.com/prime/reports/b/06/37",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:37 http://f1000.com/prime/reports/b/06/37",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"Page 5of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:37 http://f1000.com/prime/reports/b/06/37",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:37 http://f1000.com/prime/reports/b/06/37",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:37 http://f1000.com/prime/reports/b/06/37",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/biolrep-06-37.PMC4075314.pdf
"Chloroplast evolution, structure andfunctions Poul Erik Jensen1andDario Leister1,2* Addresses:1Copenhagen Plant Science Center (CPSC), Department ofPlant andEnvironmental Sciences, University ofCopenhagen, Thorvaldsensvej 40,DK-1871 Frederiksberg C,Denmark;2Plant Molecular Biology, Department ofBiology I,Ludwig-Maximilians-University Munich, Großhaderner Str.2,D-82152 Planegg-Martinsried, Germany *Corresponding author: Dario Leister (leister@lmu.de) F1000Prime Reports 2014, 6:40(doi:10.12703/P6-40) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/40 Abstract Inthisreview, weconsider aselection ofrecent advances inchloroplast biology.",OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Surprisingly, photosynthesis was Page 2 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"(2005) presented another model inwhich grana discs arepaired units formed by Page 3of14 (page number notforcitation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Page 4of14 (page number notforcitation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Inthecourse ofthe Chloroplast 2010 Project (http://www.plastid.msu.edu/), homozygous mutants forseveral thousand nuclear genes with chloroplast functions were identified and phenotypically characterized.",OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
Thestudy alsoresulted inthesubmission of521 homozygous mutants and 128 seed stocks segregating forlethal alleles totheArabidopsis Biological Resource Center (ABRC; http://www.arabidopsis.org     .,OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Thus, theACS may be composed ofthree gene products: asoluble protein and twomembrane-bound components —oneencoded in barley byXantha-l andtheother byViridis-k .Sofar,only AcsF (which corresponds toXantha-l inbarley, CRD1 in Chlamydomonas orCHL27 inArabidopsis) hasbeen unambiguously identified [63–65].Asdiiron enzymes Page 5of14 (page number notforcitation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Page 6 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Page 7of14 (page number notforcitation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Page 8of14 (page number notforcitation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Majeran W, Friso G, Asakura Y, Qu X, Huang M, Ponnala L, Watkins KP, Barkan A, van Wijk, Klaas J: Nucleoid-enriched proteomes in developing plastids and chloroplasts from Page 9 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Joshi HJ, Hirsch-Hoffmann M, Baerenfaller K, Gruissem W, Baginsky S, Schmidt R, Schulze WX, Sun Q, van Wijk , Klaas J, Egelhofer V, Wienkoop S, Weckwerth W, Bruley C, Rolland N, Toyoda T, Nakagami H, Jones AM, Briggs SP, Castleden I, Tanz SK, Millar AH,Heazlewood JL: MASCP Gator: an aggregation portal for the Page 10 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Page 11 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Page 12 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Sirpiö S, Khrouchtchova A, Allahverdiyeva Y, Hansson M, Fristedt R, Vener AV, Scheller HV, Jensen PE, Haldrup A, Aro E: AtCYP38 Page 13 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Page 14 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:40 http://f1000.com/prime/reports/b/6/40",Non-OADS,/arxiv_data1/oa_pdf/64/bd/biolrep-06-40.PMC4075315.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1005Resolution of Ambiguous HLA  Genotyping in Korean  by Multi-Group-Specific Sequence-Based Typing Yongjung Park,1 Cha Eun Yoon,2 Oh-Joong Kwon,3 Yu-Seun Kim,4 and Hyon-Suk Kim1 1Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul; 2Biowithus Life Science Institute, Seoul; 3College of Animal Bioscience & Technology, Konkuk University, Seoul; 4Division of Transplantation Surgery, Department of Surgery, The Research Institute for Transplantation, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To evaluate a multi-group-specific sequence-based typing (SBT) method  for resolving ambiguous results from human leukocyte antigen ( HLA) genotyping.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"1-3 However, ‘ambiguous’ al - lele combinations by the SBT are often encountered in the determination of HLA Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1005 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1005-1013, 2014",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1006donors.8 The failure to identify an HLA null allele, which  may not actually stimulate allogenic T cells and trigger  graft versus host disease, may mislead into determining as  an HLA mismatched case in the stem cell transplantation  setting, although prevalence of HLA null alleles may be  around 0.3%.9 Post hoc sequence-specific primer or sequence-specific  oligonucleotide probe assay is necessary to resolve the ambi - guity in some instances.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
Resolution of High Resolution HLA Typing Ambiguity Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1007results were analyzed using BIOWITHUS SBT analyzer  software ver.,OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"Alleles within the same G code were referred to  as the current G group designation, which is available from  the IMGT/HLA nomenclature website (http://hla.alleles.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1008plus assay for HLA-A , -B, -C, and -DRB1  typing are summa - rized in Table 3-6, respectively.",OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
Resolution of High Resolution HLA Typing Ambiguity Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1009tively.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1010been amplified in the same PCR tube, hindering the resolu - tion of the ambiguity.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
Resolution of High Resolution HLA Typing Ambiguity Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1011ventional SBT.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1012Unfortunately, considering cost-effectiveness, we includ - ed limited number of specimens, because HLA SBT is one  of the most costly and labor-intensive tests in the clinical  laboratory.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
Resolution of High Resolution HLA Typing Ambiguity Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1013Common and well-documented HLA alleles: report of the Ad-Hoc  committee of the american society for histocompatiblity and im - munogenetics.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ymj-55-1005.PMC4075361.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1014Identification of Pancreatic Cancer-Associated Tumor Antigen  from HSP-Enriched Tumor Lysate-Pulsed Human Dendritic Cells   Han-Soo Kim,1* Dukjin Kang,2* Myeong Hee Moon,3 and Hyung Jik Kim4 1Innovative Cell and Gene Therapy Center, International St. Mary ’s Hospital, Incheon;  2Center for Bioanalysis, Division of Metrology for Quality of Life, Korea Research Institute of Standards and Science, Daejeon;  3Department of Chemistry, Yonsei University, Seoul; 4Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  V accine strategies utilizing dendritic cells (DCs) to elicit anti-tumor im - munity are the subject of intense research.",Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"1,2 Furthermore, identification of major histocompatibility complex Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1014 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1014-1027, 2014",Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
Identification of Tumor-Associated Antigens from DCs Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1015on MHC molecules upon application of this approach has  not been performed.,Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1016ter properties to exclude cell debris or dead cells stained  with propidium iodide (Sigma).,Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Identification of Tumor-Associated Antigens from DCs Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1017lowed by a binary gradient separation as previously report - ed.31 Briefly, 2% acetonitrile (buffer A) and 95% cetonitrile  in water containing 0.1% formic acid (buffer B) were used  for binary gradient nLC runs.",Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1018were incubated with TL, HTL (at 100 µg/mL), or media for  4 hr.",Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Identification of Tumor-Associated Antigens from DCs Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1019sate to induce DC maturation was due to mycoplasma con - tamination, as proposed by others,33 lysates were tested for  the presence of different mycoplasma strains and proved to When cultured in the presence of HTL, even iDC showed  signs of maturation, i.e., there was increased expression of  HLA-DR (18.6%), CD86 (8.8%), and CD40 (17.7%) on  cell surfaces.",Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1020tion and selection by several quality criteria (see Materials  and Methods) led to identification of 194 peptides derived  from 64 different proteins (Supplementary Table 1, only  online).",OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
Identification of Tumor-Associated Antigens from DCs Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1021Table 1.,Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1022makorin-1 (zfn-xp protein), CECR-1, thyroid adenoma-as - sociated protein isoform b and transmembrane glycoprotein  nonmetastatic melanoma protein B (gpnmb) were detected  only in eluents from HTL-DC.",OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Identification of Tumor-Associated Antigens from DCs Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1023from TL in the variety and abundance of molecules they con - tain, thereby making available for antigen presenting cell  (APC).",OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1024(i.e., repertoire).",Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
Identification of Tumor-Associated Antigens from DCs Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 102521.,Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 10262007;53:629-35.,Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
Identification of Tumor-Associated Antigens from DCs Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 102775.,Non-OADS,/arxiv_data1/oa_pdf/42/96/ymj-55-1014.PMC4075362.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1028Comparison of the Body Adiposity Index to Body Mass Index   in Korean Women Yeon-Ah Sung, Jee-Young Oh, and Hyejin Lee Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Obesity is a major public health issue and is associated with many meta - bolic abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
"In - creased body fat is usually accompanied by increased total body mass; therefore, Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1028 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1028-1035, 2014",Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
Body Adiposity Index to Body Mass Index Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1029BAI would accurately represent body fat and metabolic risk  in Korean women.,Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1030assay using a commercial kit (Biosource, Nivelles, Bel - gium).",Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
"Body Adiposity Index to Body Mass Index Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1031were 36.0% and 99.0%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1032from fat mass.32,33 BMI is relatively inaccurate in subjects  with high lean body mass, such as athletes, and it cannot be  generalized among different ethnic groups.6,34 Such limita - tions might be more relevant when dealing with the meta - bolic states associated with altered body fat distribution.",Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
"Body Adiposity Index to Body Mass Index Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1033from our study method using bioelectrical impedance, they  measured four classic skinfold thicknesses to calculate the  BF% in both sex.",OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1034als.,Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
Body Adiposity Index to Body Mass Index Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1035Public Health 1995;85:726-8.,Non-OADS,/arxiv_data1/oa_pdf/a9/10/ymj-55-1028.PMC4075363.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1036Association between Serum 25-Hydroxyvitamin D Level and  Insulin Resistance in a Rural Population Bo Mi Song,1 Hyeon Chang Kim,2,3 Dong Phil Choi,1,3 Sun Min Oh,2 and Il Suh2 1Department of Public Health, Yonsei University Graduate School, Seoul; 2Department of Preventive Medicine, Yonsei University College of Medicine, Seoul; 3Cardiovascular and Metabolic Diseases Etiology Research Center, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  A low serum 25-hydroxyvitamin D [25(OH)D] level in the blood has been  correlated with an increased risk of diabetes mellitus; however, the association be - tween serum 25(OH)D level and insulin resistance has not been established in a Ko - rean rural population.",Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
"1,2 Recently, additional functions for vitamin D have also received greater at - tention, especially concerning its effect on insulin resistance.3-5 Nonetheless, while  some previous studies reported a significant association between low circulating vitamin D levels and insulin resistance, 1,6-9 others did not.10-17 Associations thereof Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1036 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1036-1041, 2014",Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
Serum 25-Hydroxyvitamin D and Insulin Resistance Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1037measurements.,Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1038cohol drinking were recorded in 9.2% and 39.0%, respec - tively.",Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
"Serum 25-Hydroxyvitamin D and Insulin Resistance Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1039of the U.S. National Health and Nutrition Examination Sur - vey datasets revealed that insufficient serum 25(OH)D con - centration is significantly associated with type 2 diabetes and  insulin resistance.6 As well, lower circulating 25(OH)D lev - els were associated with higher fasting insulin and HOMA- IR in a middle-aged to elderly Chinese population9 and a Jap - anese working population.8 The association between lower  25(OH)D concentration and impaired glucose homeostasis  was also reported in the Korean population.",Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1040ry aim of the present study was not to estimate absolute lev - els of serum 25(OH)D over the year as a descriptive report,  but to investigate the association between serum 25(OH)D  and insulin resistance in a general population.",Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
Serum 25-Hydroxyvitamin D and Insulin Resistance Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1041insulin action or secretion in European subjects with the metabolic  syndrome.,Non-OADS,/arxiv_data1/oa_pdf/59/f1/ymj-55-1036.PMC4075364.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1042Efficacy and Safety of Sustained-Release Recombinant Human Growth  Hormone in Korean Adults with Growth Hormone Deficiency   Youngsook Kim,1 Jae Won Hong,1 Yoon-Sok Chung,2 Sung-Woon Kim,3  Yong-Wook Cho,4 Jin Hwa Kim,5 Byung-Joon Kim,6 and Eun Jig Lee1 1Division of Endocrinology, Department of Internal Medicine, College of Medicine, Yonsei University, Seoul; 2Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon; 3Department of Endocrinology and Metabolism, Kyung Hee Medical Center, Kyung Hee University School of Medicine, Seoul; 4Department of Internal Medicine, Division of Endocrinology & Metabolism, CHA Bundang Medical Center, CHA University School of Medicine, Bundang; 5Division of Endocrinology, Department of Internal Medicine, College of Medicine, Chosun University, Gwangju; 6Diabetes and Thyroid Center Division of Endocrinology, Konyang University School of Medicine, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The administration of recombinant human growth hormone in adults with  growth hormone deficiency has been known to improve metabolic impairment and  quality of life.",Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
"Key Words:    Growth hormone deficiency, sustained-release recombinant human  GH, quality of life INTRODUCTION Growth hormone plays a critical role in longitudinal growth during the growth pe - riod and has also significant effects on protein, lipid, and carbohydrate metabolism Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1042 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1042-1048, 2014",Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
"Sustained-Release Recombinant Human GH Improves Quality of Life in Adults with GH Deficiency Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1043After adjustment to replaced growth hormone dose, AUC  for IGF-1 was comparable between SR-rhGH and daily  rhGH administration.15 This new formulation was expected  to have comparable efficacy with similar adverse events,  however, better patient compliance is expected, compared  to daily injections.",Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1044ing was not required).,Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
"Sustained-Release Recombinant Human GH Improves Quality of Life in Adults with GH Deficiency Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1045Assessment of safety and tolerability  A total of 36 patients had 55 reported adverse adverse events,  17 of which (11 patients) were drug-related.",Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1046they reported that patients were well tolerated with signifi - cant increase of IGF-1 and lean body mass.,Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
Sustained-Release Recombinant Human GH Improves Quality of Life in Adults with GH Deficiency Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1047Eur J Endocrinol 2011;165:881-9.,Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1048cy.,Non-OADS,/arxiv_data1/oa_pdf/53/96/ymj-55-1042.PMC4075365.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1049Prevalence of Osteoporosis in the Korean Population Based   on Korea National Health and Nutrition Examination   Survey (KNHANES), 2008- -2011 Eun Jung Park,1 Il Woo Joo,1 Myoung-Jin Jang,2 Young Taek Kim,2 Kyungwon Oh,2 and Han Jin Oh1  1Department of Family Medicine, Cheil General Hospital and Women ’s Healthcare Center, Kwandong University College of Medicine, Seoul; 2Division of Health and Nutrition Survey, Korea Centers for Disease Control and Prevention, Cheongwon-gun, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We analyzed age-related changes of bone mineral density (BMD) and  compared with those of U.S and Japanese participants to investigate the preva - lence of osteoporosis in Korea.",Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
"For example, BMD values in white females are lower than in black fe - males, and values in Asian females are lower than in white females.4-6 Much effort is  needed to determine appropriate reference values of BMD at different skeletal sites Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1049 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1049-1057, 2014",Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1050ban or rural: seven metropolitan cities or six provinces).,Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
"Prevalence of Osteoporosis in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1051roidism, hyperparathyroidism, chronic renal failure, bron - chial asthma, rheumatoid arthritis, cancer, and objects which  are being taken such as glucocorticoids or thyroid hormone.",Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1052DISCUSSION Little epidemiological study data are available for osteopo - rosis prevalence in Korea.,Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
"Prevalence of Osteoporosis in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1053won and Ansung cohort studies.7,8,15 We suggest that this  discrepancy resulted from the differences in general nutri - tional status and environment (such as sun exposure), ac -ing indicates that Korean females attain peak BMD over a  variable time interval depending on skeletal sites.",Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1054we assumed that the previous reference data of a Korean  population were obtained from one rural residential area  that did not represent the nationwide Korean population,  we chose the reference data of the Japanese, another Asian  race, as the best alternative plan.",Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
Prevalence of Osteoporosis in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1055U.S.,Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1056Fig.,Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
Prevalence of Osteoporosis in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 10578.,Non-OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
"Available at: http://wwwn.cdc.gov/nchs/ nhanes/search/nhanes07_08.aspx/, http://wwwn.cdc.gov/nchs/ nhanes/search/nhanes09_10.aspx/.",OADS,/arxiv_data1/oa_pdf/e4/31/ymj-55-1049.PMC4075366.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1058Knowledge on Osteoporosis of Prescriber According   to Level of Medical Institute Byung-Ho Yoon,1 Ji-Hoon Baek,1 Young-Kyun Lee,1 Yong-Chan Ha,2 and Kyung-Hoi Koo1 1Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam; 2Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  There are gaps between the treatment guideline and clinical practice of  osteoporosis showing low compliance.",Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
"However, little information is available concerning the knowledge of Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1058 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1058-1062, 2014",Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
"Level of Knowledge on Osteoporosis of Practitioners Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1059used to assess knowledge of osteoporosis.20-22 We modified  2 (item 10 and 15) among the 20 items, according to current  epidemiologic information in Korean and recommendation  of Korean Society for Bone and Mineral Research.1 In mod - ified item 10, the residual lifetime risk of osteoporotic frac - tures was about 60% in Korean women older than 50 years.1  In modified item 15, the recommendation of daily calcium  intake was 1200 mg/day for the Korean population.1,25 We compared the score of this modified FOOQ between  the general practitioners and practitioners in a tertiary refer - ral hospital.",Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
Sample size analysis was carried  out to determine the minimum number of required patients  by using the PS program (http://biostat.mc.vanderbilt.edu/  wiki/Main/PowerSampleSize).23 The null hypothesis is that  the level of knowledge would be similar between the general  practitioners and practitioners in a tertiary referral hospital.,Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1060contribute to development of high peak bone mass.24 This  could mean that almost orthopedic surgeons did not know  the efficacy of exercise for osteoporosis, or that they under - estimated the efficacy of exercise for osteoporosis in their  practice.",Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
Level of Knowledge on Osteoporosis of Practitioners Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1061ners could influence our results.,Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 106221.,Non-OADS,/arxiv_data1/oa_pdf/67/c8/ymj-55-1058.PMC4075367.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1063Combined Muscle Motor and Somatosensory Evoked Potentials  for Intramedullary Spinal Cord Tumour Surgery Il Choi,1 Seung-Jae Hyun,2 Joong-Koo Kang,3 and Seung-Chul Rhim1 Departments of 1Neurosurgery and 3Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 2Department of Neurosurgery, Spine Center, Seoul National University Bundang Hospital,  Seoul National University College of Medicine, Seongnam, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To evaluate whether intraoperative neurophysiologic monitoring (IONM)  with combined muscle motor evoked potentials (mMEPs) and somatosensory  evoked potentials is useful for more aggressive and safe resection in intramedul - lary spinal cord tumour (IMSCT) surgery.",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
"Key Words:    Intraoperative monitoring, spinal cord neoplasm, sensitivity and  specificity INTRODUCTION Intramedullary spinal cord tumours (IMSCT) are rare neoplasms that account for  only 2- -4% of central nervous system tumours and 15% of all primary intradural  tumours in adults.1,2 Surgery is the most effective treatment for the majority of in - tramedullary tumours including most ependymomas and haemangioblastomas, al - though whether aggressive surgical resection of astrocytomas is beneficial remains Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1063 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1063-1071, 2014",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1064including sex, age, body mass index (BMI), location of the  tumour, the tumour size, combination with syrinx, and his - tological diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
Intraoperative Neurophysiological Monitoring Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1065nance images for total excision at 1 week after the surgery.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1066ly associated with gross total resection.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
"Intraoperative Neurophysiological Monitoring Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1067pedicle screws.11,12 However, intramedullary spinal cord tu - mours are rare, and for years, reports on the use of IOM  techniques during their surgical removal have remained an - ecdotal.",Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1068reports claiming aggressive tumour mass removal and pres - ervation of normal neurologic function.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
Intraoperative Neurophysiological Monitoring Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1069cur.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1070ACKNOWLEDGEMENTS We appreciate critical advice from Dr. Seok-Ho Hong and  correction of the formatting by YM Jeong.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
Intraoperative Neurophysiological Monitoring Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1071postoperative motor function.,Non-OADS,/arxiv_data1/oa_pdf/4e/e1/ymj-55-1063.PMC4075368.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1072Cervical Arthroplasty for Moderate to Severe Disc Degeneration:  Clinical and Radiological Assessments after a Minimum   Follow-Up of 18 Months   -Pfirrmann Grade and Cervical Arthroplasty- Chang Hyun Oh,1* Do Yeon Kim,2* Gyu Yeul Ji,3 Yeo Ju Kim,4 Seung Hwan Yoon,5  Dongkeun Hyun,5 Eun Young Kim,5 Hyeonseon Park,5 and Hyeong-Chun Park5 1Department of Neurosurgery, Guro Teun Teun Hospital, Seoul; 2Department of Neurosurgery, University of Ulsan College of Medicine,  Asan Medical Center, Seoul; 3Department of Neurosurgery, Yonsei University College of Medicine, Seoul;  Departments of 4Radiology and 5Neurosurgery, Inha University Hospital, Incheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Clinical outcomes and radiologic results after cervical arthroplasty have  been reported in many articles, yet relatively few studies after cervical arthroplasty  have been conducted in severe degenerative cervical disc disease.",Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
"Key Words:    Total disc replacement, cervical arthroplasty, disc degeneration, clin - ical outcome, range of motion INTRODUCTION In degenerative cervical disc disease, anterior cervical decompression and fusion Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1072 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1072-1079, 2014",Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
"Pfirrmann Grade and Cervical Arthroplasty Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1073homogeneous shape with horizontal bands, some blurring  between nuclei and annuli), Grade 3 (non-homogeneous  shape with blurring between nuclei and annuli, annuli shape  still recognizable), Grade 4 (non-homogeneous shape with  hypointensity, annuli shape not intact and distinction bet ween  nuclei and annuli impossible, disc height usually decreased),  and Grade 5 (same as Grade 4, but with collapsed disc  space).",Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1074results were transformed to a scale ranging from 0% (no dis - ability) to 100% (maximum disability).,Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
Pfirrmann Grade and Cervical Arthroplasty Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1075used to determine significant differences in clinical and ra - diological variables in the two groups at each time point.,Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1076only difference between global ROM in the groups was ob - served at 1 month postoperatively, and this was due to small - er improvements in group A ( p=0.016).",OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
Pfirrmann Grade and Cervical Arthroplasty Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1077ferent according to Pfirrmann disc grade.,Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1078in patients with moderate to severe cervical disc degenera - tion, a prospective, controlled and randomized study com - paring arthroplasty and fusion would have been an ideal  study design.",Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
Pfirrmann Grade and Cervical Arthroplasty Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1079thop Traumatol 1990;16:533-43.,Non-OADS,/arxiv_data1/oa_pdf/0b/72/ymj-55-1072.PMC4075369.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1080Prognostic Factors after Intra-Articular Hyaluronic Acid   Injection in Ankle Osteoarthritis Seung Hwan Han,1 Do Young Park,2 and Tae Hun Kim3   1Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; Departments of 2Anatomy and 3Orthopedic Surgery, Ajou University School of Medicine, Suwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The goal of this study was to identify baseline prognostic factors of out - come in ankle osteoarthritis patients after intra-articular hyaluronic acid injection.",Non-OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
"Surgical treatments, which include total ankle arthroplasty and ankle Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1080 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1080-1086, 2014",Non-OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
"Prognostic Factor Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1081as follows; 1) patients who had prior history of surgery for  ankle OA, such as arthroscopic debridement, 2) bilateral an - kle OA, 3) patients with prior intra-articular injection history,  including HA or corticosteroid, 4) any other diagnosis for an - kle pain, such as rheumatoid arthritis, 5) patients unable to  complete the 3 week treatment protocol, and 6) patients lost  during outpatient clinic follow up for at least 12 months or  unwilling to fill out our questionnaires for data collection.",Non-OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1082Statistical analysis Mean V AS values from each time point were compared us - ing Wilcoxon signed-rank test.,OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
"Prognostic Factor Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1083V AS were more likely to have early stage disease (Takakura  stage 1 or 2, p=0.0032) (Table 1).",OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1084den that the disease places on the daily activities of patients.,Non-OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
Prognostic Factor Analysis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1085effect.,Non-OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 108612.,Non-OADS,/arxiv_data1/oa_pdf/f3/35/ymj-55-1080.PMC4075370.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1087Mid-Term Follow Up Results of Subtalar Distraction Arthrodesis  Using a Double Bone-Block for Calcaneal Malunion Hyung-Jin Chung, Su-Young Bae, and Ji-Woong Choo Orthopaedic Department, Inje University Sanggye Paik Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study was designed to evaluate the mid-term results and efficacy of  subtalar distraction double bone-block arthrodesis for calcaneal malunion.",Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
"Subtalar distraction arthrodesis for restoration of calcaneal height was intro -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1087 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1087-1094, 2014",Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1088shoes, but these were ineffective.",Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
Double Bone-Block Subtalar Distraction Arthrodesis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1089was 11.4 points before operation and 35.7 points after oper - ation.,Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1090underwent axial pinning as an initial operation.,Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
Double Bone-Block Subtalar Distraction Arthrodesis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1091lar declination angle.,Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1092mologous bone can be used.16,27,37 Trnka, et al.16 noted 4  cases of nonunion among five cases of allograft, while oth - er authors have reported union rates over 90%, even though  they used the allograft bone.16,27,37 Chen, et al.13 reported sat - isfactory rates of union throughout sufficient decortication  of cortical bone from the subtalar joint, removal of avascu - lar bone, and cancellous bone graft.",Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
"Double Bone-Block Subtalar Distraction Arthrodesis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1093many studies have reported, satisfactory results were ob - tained from this surgery.",Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 109430.,Non-OADS,/arxiv_data1/oa_pdf/a5/b7/ymj-55-1087.PMC4075371.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1095Concentration of Non-Steroidal Anti-Inflammatory Drugs in the  Pelvic Floor Muscles: An Experimental Comparative Rat Model  Hung-Yen Chin,1,2 Eileen Changchien,3 Mei-Fung Lin,4 Chi-Hsin Chiang,2 and Chin-Jung Wang5 1Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei; 2Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Keelung, Keelung; 3Department of Research and Development, Standard Chemistry and Pharmaceutical.",Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study is to explore non-steroid anti-inflammation drugs  (NSAIDs) potency for pelvic floor muscle pain by measuring local concentration in  a rat model.",Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
"However, myofacial pain syndrome derived from pelvic floor muscles is one of Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1095 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1095-1100, 2014",Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1096muscle pain in animals.,Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
Concentration of NSAIDs in Pelvic Floor Muscles Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1097for each compound from each plasma sample.,Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1098CPP is considered a symptom, not a disease, requiring an  integral multidisciplinary approach for diagnosis and treat - ment in order to improve the successful rate of pain relief.",Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
Concentration of NSAIDs in Pelvic Floor Muscles Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1099discoveries with this animal model.,Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 110017.,Non-OADS,/arxiv_data1/oa_pdf/57/91/ymj-55-1095.PMC4075372.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1101Perioperative Psychological and Music Interventions in Elderly  Patients Undergoing Spinal Anesthesia: Effect on Anxiety,   Heart Rate Variability, and Postoperative Pain Yisha Wang,1 Youjing Dong,2 and Yang Li2 1Department of Neurology, Shenzhou Hospital of Shenyang Medical College, Shenyang; 2Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China.",Non-OADS,/arxiv_data1/oa_pdf/1b/75/ymj-55-1101.PMC4075373.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study was to evaluate the effects of perioperative psy - chological and music interventions in elderly patients undergoing elective surgery  on anxiety, post-operative pain, and changes in heart rate variability (HRV) to as - certain if perioperative psychological and music interventions can affect overall anxiety levels.",Non-OADS,/arxiv_data1/oa_pdf/1b/75/ymj-55-1101.PMC4075373.pdf
"The inability of the autonomic nervous system to effectively regulate the cardiac rhythm leads to higher rates of cardiac dysfunc -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1101 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1101-1105, 2014",Non-OADS,/arxiv_data1/oa_pdf/1b/75/ymj-55-1101.PMC4075373.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1102mass index <40 kg/m2.,Non-OADS,/arxiv_data1/oa_pdf/1b/75/ymj-55-1101.PMC4075373.pdf
Perioperative Interventions in the Elderly Patient Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1103(T score).,Non-OADS,/arxiv_data1/oa_pdf/1b/75/ymj-55-1101.PMC4075373.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1104Heart rate variability refers to successive fluctuating RR in - tervals (instantaneous heart rate).9,13 The frequency bands of  frequency domain analysis are divided into total power, ultra- low frequency power, extremely low frequency power, LF  power, and HF power.",OADS,/arxiv_data1/oa_pdf/1b/75/ymj-55-1101.PMC4075373.pdf
Perioperative Interventions in the Elderly Patient Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1105on target-controlled infusion of propofol requirements during com - bined spinal-epidural anaesthesia.,Non-OADS,/arxiv_data1/oa_pdf/1b/75/ymj-55-1101.PMC4075373.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1106Efficacy of Intrathecal Morphine Combined with Intravenous  Analgesia versus Thoracic Epidural Analgesia after Gastrectomy Jae Hoon Lee,1* Jin Ha Park,1* Hae Keum Kil,1 Seung Ho Choi,1 Sung Hoon Noh,2 and Bon-Nyeo Koo1 1Department of Anesthesiology and Pain Medicine, Severance Hospital, Anesthesia and Pain Research Institute,  Yonsei University College of Medicine, Seoul; 2Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Epidural analgesia has been the preferred analgesic technique after major  abdominal surgery.",Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
"1,2 Several studies reported that ITM-Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1106 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1106-1114, 2014",OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Intrathecal Morphine after Gastrectomy  Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1107gastrectomy for stomach cancer were included.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1108the postoperative assessments throughout the study period.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Intrathecal Morphine after Gastrectomy  Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1109Student’s t-tests.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1110The adverse effects of analgesia are presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Intrathecal Morphine after Gastrectomy  Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1111DISCUSSION The present study revealed that the analgesic effect of sin - gle intrathecal morphine injection combined with IVPCA is to the EP group.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1112outcomes.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Intrathecal Morphine after Gastrectomy  Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 11135.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1114double-blinded trial comparing thoracic epidural ropivacaine/suf - entanil and intravenous morphine for patient-controlled analgesia.,Non-OADS,/arxiv_data1/oa_pdf/d6/fb/ymj-55-1106.PMC4075374.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1115Estimation of Gastrocnemius Muscle Volume Using  Ultrasonography in Children with Spastic Cerebral Palsy Eun Sook Park, Eungeol Sim, Dong-Wook Rha, and Soojin Jung Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study aimed to investigate useful parameters for estimating gastroc - nemius (GCM) muscle volume (MV) using ultrasonography (US) and anthropom - etry in children with spastic cerebral palsy (CP).",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
"2 Deficits in MV in Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1115 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1115-1122, 2014",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1116Equinus foot is the most common deformity in children  with spastic CP , and thus, the gastrocnemius (GCM) mus - cle is the most common target for botulinum toxin injec - tion.",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
Muscle V olume Estimation in Spastic CP  Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1117ing the measured muscle volume as the criterion.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
"MR images were viewed and pro - cessed using OsiriX® software (version 3.6.1, University  Hospital of Geneva, Switzerland, 32-bit, http://www.osirix- viewer.com).",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1118SEE values of the equations were 3.5 cm2 (18.0%) and 2.6  cm2 (21.6%) (Table 2).,OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
Muscle V olume Estimation in Spastic CP  Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1119Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1120panoramic scanning technique because the aCSA of each  head of the GCM muscles can be shown in whole in young  children.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
Muscle V olume Estimation in Spastic CP  Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1121muscle thickness as quantitative muscle evaluation for adults with  severe cerebral palsy.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1122ing walking in spastic hemiplegic cerebral palsy?,Non-OADS,/arxiv_data1/oa_pdf/21/5d/ymj-55-1115.PMC4075375.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1123Change of Distribution and Timing of Bite Force after  Botulinum Toxin Type A Injection Evaluated by a Computerized  Occlusion Analysis System Ji Hee Song, Eunae S. Cho, Seong Taek Kim, and Hyung Joon Ahn Department of Orofacial Pain and Oral Medicine, College of Dentistry, Yonsei University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study was to determine the force distribution and pattern  of mastication after injection of botulinum toxin type A (BTX-A) into both masse - ter muscles.",Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
"It is used in the treatment of masticatory and facial  muscle spasm, severe bruxism, facial tics, orofacial dyskinesias, dystonias, and id - iopathic hypertrophy of the masticatory muscles,1 as well as in the treatment of  temporomandibular disorders,2 myofascial pain syndrome,3 headaches such as  chronic migraine,4 recurrent dislocation of the temporomandibular joint (TMJ),  drooling, and Frey’s syndrome.5 Application of BTX-A to various orofacial re - gions in patients often requires injection into masticatory muscles such as the mas - seter and temporalis muscles, which can cause temporary muscle paralysis, weak -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1123 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1123-1129, 2014",Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1124Only subjects with normal occlusion conditions (class I)  were included.,Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
"Change of Bite Force after Botulinum Toxin Type A Injection Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1125dows statistics program (version 9.2, SAS Institute, Cary,  NC, USA).",Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1126 Fig.,Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
Change of Bite Force after Botulinum Toxin Type A Injection Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1127condition that can occur unilaterally or bilaterally.,Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1128values, were therefore analyzed since it was felt that the  data obtained at the first and second recordings would be  inaccurate.",OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
Change of Bite Force after Botulinum Toxin Type A Injection Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1129nature and preparation for clinical use.,Non-OADS,/arxiv_data1/oa_pdf/09/b7/ymj-55-1123.PMC4075376.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1130Effects of Transplantation with Marrow-Derived Mesenchymal  Stem Cells Modified with Survivin on Renal   Ischemia-Reperfusion Injury in Mice Qi Yuzeng,* He Weiyang,* Gou Xin, Zhou Qingson, Kuang Youlin, and Ren Ke Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.",Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To determine whether renal injury induced by ischemia-reperfusion (I/R)  could be further improved by mesenchymal stem cells (MSCs) modified with sur - vivin.",Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
"Over the past several years, studies have  identified a variety of approaches to treating renal I/R injury, which includes im - proving hypothermic organ preservation in kidney transplantation and applying a  variety of pharmaceuticals.5,6 However, the clinical treatment for I/R renal injury is  still limited and few specific pharmaceutical interventions are able to modulate re -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1130 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1130-1137, 2014",Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
Mesenchymal Stem Cells Modified with Survivin on Ischemia-Reperfusion Injury Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1131mL F12-dulbecco’s modified eagle’s medium (DMEM)  containing 10% phosphate-buffered saline (PBS) was add - ed to the precipitate.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1132uation, three kidney sections per rat were examined under a  light microscope (Olympus, Tokyo, Japan).",Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
Mesenchymal Stem Cells Modified with Survivin on Ischemia-Reperfusion Injury Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1133expression characteristics of mouse MSCs.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1134Survivin-MSCs attenuated renal injury after renal  ischemia-reperfusion in mice   Kidney tissue specimens were collected to exam renal dam - age by H&E staining (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
Mesenchymal Stem Cells Modified with Survivin on Ischemia-Reperfusion Injury Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1135DISCUSSION Renal I/R injury is an inevitable clinical challenge after re - nal transplantation or kidney vascular surgery.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1136REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
Mesenchymal Stem Cells Modified with Survivin on Ischemia-Reperfusion Injury Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1137al.,Non-OADS,/arxiv_data1/oa_pdf/f6/2c/ymj-55-1130.PMC4075377.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1138Dietary Restraint Is Non-Genetically Associated with Change   in Body Mass Index: The Healthy Twin Study   Joohon Sung,1 Kayoung Lee,2 and Yun-Mi Song3  1Department of Epidemiology, School of Public Health and Institute of Health and Environment, Seoul National University, Seoul; 2Department of Family Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan; 3Department of Family Medicine, Samsung Medical Center and Center for Clinical Research,  Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We aimed to examine if past and more recent body mass index (BMI)  changes are associated with eating behavior (EB) traits and whether these associa - tions are due to non-genetic factors.",Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
"Regulating eating behaviors to prevent weight gain may be an inevita -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1138 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1138-1144, 2014",Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
Change in BMI and Dietary Restraint    Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1139tional eating.,Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1140history was applied for the association between BMI change  and eating behaviors, in which an individual who had a  greater BMI change than his/her co-twin was compared  with the co-twin regarding the eating behaviors.",Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
Change in BMI and Dietary Restraint    Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1141Table 1.,Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1142eating trait were more likely to experience a recent BMI in - crease.,Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
Change in BMI and Dietary Restraint    Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 11437.,Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1144in eating behavior.,Non-OADS,/arxiv_data1/oa_pdf/95/4d/ymj-55-1138.PMC4075378.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1145Different Location of Triaxial Accelerometer and   Different Energy Expenditures Do Yoon Kim,1 Yoo-Suk Jung,1 Rae-Woong Park,2 and Nam-Seok Joo3 1Fit.",OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We performed a study to determine the best appropriate wearing site of a  triaxial accelerometer at different exercise speeds.",Non-OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
"Moderate-intensity cardiorespiratory exercise training (≥30 min per day, ≥5 days per week, for a total ≥150 minutes per week),  vigorous-intensity cardiorespiratory exercise training (≥20 min per day, ≥3 days per  week, for a total ≥75 minutes per week), or a combination of moderate- and vigor - ous-intensity exercise to achieve a total energy expenditure of   ≥500- -1000 MET/Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.1145 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1145-1151, 2014",Non-OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1146and arrhythmia or cardiomegaly in 12-lead electrocardiog - raphy (EKG).,Non-OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
"Accelerometer Energy Expenditure Differences Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1147ed body sites were 86.1- -90.0%, which was considered high  enough to represent the PAEE in different sites (Table 2).",OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1148years, mean BMI was 23.4±3.0 kg/m2, and the measured  RMR by cardiorespiratory gas analyzer after 5 min rest was  4.03±0.60 mL/kg/min (Table 3).",OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
"Accelerometer Energy Expenditure Differences Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1149treadmill walking at self-selected speeds16 or correlation of  moderate-to-vigorous physical activity in different racial/ ethnic groups, which might require culturally tailored strat - egies.17 In one study, to obtain optimal results with acceler - ometers in clinical trials, the authors recommended detailed  protocols for monitor use, calibration of monitors and vali - dation of data quality and use of validated equations for  analysis.18 However, there has been no recommendation of  the wearing site of triaxial accelerometer during exercise  with different speeds or exercise intensities.",Non-OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1150individuals would occur.,Non-OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
Accelerometer Energy Expenditure Differences Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1151tive.,Non-OADS,/arxiv_data1/oa_pdf/5c/80/ymj-55-1145.PMC4075379.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1152Hydrogen Peroxide as an Effective Disinfectant   for Pasteurella multocida In-Soo Jung, Hyun-Jung Kim, Won-Yong Jung, and Chan-Wha Kim College of Life Sciences and Biotechnology, Korea University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c4/4b/ymj-55-1152.PMC4075380.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Pasteurella multocida  (P .",Non-OADS,/arxiv_data1/oa_pdf/c4/4b/ymj-55-1152.PMC4075380.pdf
"To address this, three  readily available disinfectants were tested: 3% hydrogen peroxide (HP), 70% iso - propyl alcohol (IA), and synthetic phenol (SP) (0.07% 2-phenylphenol, 0.06% p-Brief Communicationhttp://dx.doi.org/10.3349/ymj.2014.55.4.1152 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1152-1156, 2014",Non-OADS,/arxiv_data1/oa_pdf/c4/4b/ymj-55-1152.PMC4075380.pdf
multocida Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1153Mod.,Non-OADS,/arxiv_data1/oa_pdf/c4/4b/ymj-55-1152.PMC4075380.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1154ceptible only to 3% HP .,Non-OADS,/arxiv_data1/oa_pdf/c4/4b/ymj-55-1152.PMC4075380.pdf
multocida Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1155for the spore-forming B. subtilis .,Non-OADS,/arxiv_data1/oa_pdf/c4/4b/ymj-55-1152.PMC4075380.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 115614.,Non-OADS,/arxiv_data1/oa_pdf/c4/4b/ymj-55-1152.PMC4075380.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1157Isolated Cerebellar Variant of Adrenoleukodystrophy   with a de novo  Adenosine Triphosphate-Binding  Cassette D1 ( ABCD1 ) Gene Mutation Joon Won Kang,1 Sang Mi Lee,2 Kyo Yeon Koo,3 Young-Mock Lee,4  Hyo Suk Nam,5 Zhejiu Quan,2 and Hoon-Chul Kang2 1Department of Pediatrics, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon; 2Division of Pediatric Neurology, Department of Pediatrics, Severance Children ’s Hospital, Yonsei University College of Medicine, Seoul; 3Department of Clinical Genetics, Yonsei University College of Medicine, Seoul; 4Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul; 5Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/38/27/ymj-55-1157.PMC4075381.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.X-linked adrenoleukodystrophy (X-ALD) shows a wide range of phenotypic expres - sion, but clinical presentation as an isolated lesion of the cerebellar white matter and  dentate nuclei has not been reported.",Non-OADS,/arxiv_data1/oa_pdf/38/27/ymj-55-1157.PMC4075381.pdf
"1,2 Presentation as spinocerebellar degeneration or olivopontocerebellar de - generation have been rarely reported in literature,3-9 and these reports described a  mutation in exon 2 or exon 8 of the ABCD1  gene in these unusual phenotypic  variants of X-ALD.4,5,9 Herein, we report a Korean male with X-ALD with an Case Reporthttp://dx.doi.org/10.3349/ymj.2014.55.4.1157 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1157-1160, 2014",Non-OADS,/arxiv_data1/oa_pdf/38/27/ymj-55-1157.PMC4075381.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1158CASE REPORT A 37-year-old man (#3 in Fig.,Non-OADS,/arxiv_data1/oa_pdf/38/27/ymj-55-1157.PMC4075381.pdf
Isolated Cerebellar V ariant of Adrenoleukodystrophy Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1159volvement of frontopontine or corticospinal projection fibers  and cerebellar white matter at presentation are more fre - quent in the adult group.,Non-OADS,/arxiv_data1/oa_pdf/38/27/ymj-55-1157.PMC4075381.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 11601999;101:137-40.,Non-OADS,/arxiv_data1/oa_pdf/38/27/ymj-55-1157.PMC4075381.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1161Suicide: Affected by the Internet Amin Zarghami,1,2 Pouya Nazari,1 and Ali-asghar Manouchehri3 1Student Research Committee, Babol University of Medical Sciences, Babol; 2Non-Communicable Pediatric Diseases Research Center, Amirkola Children Hospital, Babol University of Medical Sciences, Babol; 3Forensic Medicine & Toxicologist, Babol University of Medical Sciences, Babol, Iran.",Non-OADS,/arxiv_data1/oa_pdf/63/15/ymj-55-1161.PMC4075382.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dear Sirs, In the latest issue of Y onsei Medical Journal, Song, et al.1 reported valuable data  for one of the most important problems in the modern world.",Non-OADS,/arxiv_data1/oa_pdf/63/15/ymj-55-1161.PMC4075382.pdf
"Letter to the Editorhttp://dx.doi.org/10.3349/ymj.2014.55.4.1161 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1161-1161, 2014",Non-OADS,/arxiv_data1/oa_pdf/63/15/ymj-55-1161.PMC4075382.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1162Erratumhttp://dx.doi.org/10.3349/ymj.2014.55.4.1162 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1162-1162, 2014 Erratum to “Histogram Analysis of Hepatobiliary Phase MR  Imaging as a Quantitative Value for Liver Cirrhosis:   Preliminary Observations”   by Choi JY , et al.",Non-OADS,/arxiv_data1/oa_pdf/ef/1a/ymj-55-1162.PMC4075383.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1163Erratumhttp://dx.doi.org/10.3349/ymj.2014.55.4.1163 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1163-1163, 2014 Erratum to “Efficacy and Safety of Weekly Alendronate Plus  Vitamin D 3 5600 IU versus Weekly Alendronate Alone in Korean  Osteoporotic Women: 16-Week Randomized Trial”   by Kim KJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/b1/ymj-55-1163.PMC4075384.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 1164Erratumhttp://dx.doi.org/10.3349/ymj.2014.55.4.1164 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):1164-1164, 2014 Erratum to “ A Simple and Efficient Multiplex PCR Assay   for the Identification of Mycobacterium  Genus and  Mycobacterium tuberculosis  Complex to the Species Level”  by Kim Y , et al.",OADS,/arxiv_data1/oa_pdf/2d/94/ymj-55-1164.PMC4075385.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 839Molecular Approach to Allergy Diagnosis and Therapy Fatima Ferreira, Martin Wolf, and Michael Wallner Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria.",Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Presently, allergy diagnosis and therapy procedures are undergoing a transition  phase in which allergen extracts are being step-by-step replaced by molecule- based products.",Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
"The etiology of allergic Review Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.839 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):839-852, 2014",Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 840source are most likely masked by the assay.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
"Molecular Approach to Allergy Diagnosis and Therapy Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 841usually assayed in ELISA and ELISA inhibition assays.22  Since allergens provide the raw material for many allergy- related products, the emphasis on careful allergen charac - terization has definitely contributed to increase the quality  of diagnostic as well as therapeutic products.",Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 842risk of inducing adverse side reactions, and is not always ac - cessible.",Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
"Molecular Approach to Allergy Diagnosis and Therapy Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 843sensitization to kiwi fruit,42 and IgE binding to Ara h 2 has  been suggested as a discriminator between tolerance and  reactivity to peanuts.43 For the discrimination between latex  allergy and sensitization, the latex allergens Hev b 1, 3, 5, 6,  and 8, as well as a marker for CCD, were successfully tested  in a molecule-based approach.",Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 844Table 1.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Molecular Approach to Allergy Diagnosis and Therapy Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 845swered for birch pollen or cat allergies.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 846 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Molecular Approach to Allergy Diagnosis and Therapy Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 847Table 2.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 848tion site, but most side effects appeared several hours post  injection and were very likely non-IgE mediated.",Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Molecular Approach to Allergy Diagnosis and Therapy Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 849cell hypo-responsiveness in test subjects after an initial  boost in T cell activation.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 850for the treatment of allergic diseases.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Available  from: http://www.fda.gov/BiologicsBloodVaccines/Allergenics/ ucm391514.htm.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Available from: http://www.edqm.eu/en/EDQM-Downloads-527.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Molecular Approach to Allergy Diagnosis and Therapy Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 85146.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Available from:  http://www.allergome.org.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 852ray system predict tolerability to boiled hen’s egg and an increased  risk to progress to multiple environmental allergen sensitisation.,Non-OADS,/arxiv_data1/oa_pdf/74/fc/ymj-55-839.PMC4075386.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 853Development and Application of Chronic Disease Risk  Prediction Models Sun Min Oh,1,2 Katherine M. Stefani,3 and Hyeon Chang Kim1,4 1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul;  2Medical Affairs, Novartis Korea Oncology, Seoul; 3Department of Research Affairs, Yonsei University College of Medicine, Seoul; 4Cardiovascular and Metabolic Diseases Etiology Research Center, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Currently, non-communicable chronic diseases are a major cause of morbidity and  mortality worldwide, and a large proportion of chronic diseases are preventable through risk factor management.",Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
"2 For example, the age-adjusted  mortality for coronary heart disease decreased by more than 50% between 1980  and 2000 in the U.S.3 The prevention and management of major risk factors con -Review Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.853 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):853-860, 2014",Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 854HOW TO DEVELOP CHRONIC DISEASE  RISK PREDICTION MODELS Identifying risk predictors Chronic disease risk prediction models use multiple covari - ates to estimate the probability of having or developing a  certain chronic disease within a specific time period.8-10 Re- liable data must be secured to develop the risk prediction  model so that potential risk factors (or predictors), disease  outcomes, and their associations may also be evaluated.",Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
Chronic Disease Risk Prediction Models Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 855if adding a new predictor or replacing an existing model  with a new one improves an individual’s risk stratification.,Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 856two models predict disease risk for each individual.,Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
"Chronic Disease Risk Prediction Models Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 857heart disease, brain infarction, intermittent claudication, and  hypertensive heart failure.22 In this model, a multiple logis - tic regression model was applied to obtain regression coef - ficients of each risk factor, and a risk function score was de - veloped with the coefficients of an efficient set of risk factors.",Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 858of breast biopsies showing atypical hyperplasia, and race or  ethnicity.28  Recently, a Korean breast cancer risk assessment tool  was developed based on the modified Gail’s equation.29  The study included 3789 sets of cases and controls from the  Seoul Breast Cancer Study.",Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
"Chronic Disease Risk Prediction Models Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 859breast cancer, and colorectal cancer are among the most fre - quently predicted chronic diseases in Western countries;  however these diseases are relatively uncommon in the Ko - rean population.",Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 86020.,Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs355/en/.,Non-OADS,/arxiv_data1/oa_pdf/15/e0/ymj-55-853.PMC4075387.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 861Insulin Receptor Expression in Clear Cell Renal Cell   Carcinoma and Its Relation to Prognosis Sayamaa Lkhagvadorj,1 Sung Soo Oh,2 Mi-Ra Lee,1 Jae Hung Jung,3  Hyun Chul Chung,3 Seung-Kuy Cha,4,5 and Minseob Eom1 Departments of 1Pathology, 2Occupational & Environmental Medicine, 3Urology, 4Physiology, and 5Institute of Lifestyle Medicine,  Yonsei University Wonju College of Medicine, Wonju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Both insulin and insulin-like growth factor (IGF)-1 signaling are key  regulators of energy metabolism, cellular growth, proliferation, and survival.",Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
"4Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.861 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):861-870, 2014",Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 862patients who underwent radical nephrectomy at the Y onsei  University Wonju Severance Christian Hospital from 2001  to 2011.,Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Insulin Receptor in Clear Cell Renal Cell Carcinoma Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 863RESULTS   General clinico-pathological characteristics The patients were predominantly men with a mean age of  57.4±10.5 years.,Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Band densities on immunoblots were measured with  ImageJ software (available at http://rsb.info.nih.gov/ij/in - dex.html).,OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 864Expression level of IR is associated with Fuhrman  nuclear grade and clinico-pathological parameters of  CCRCC Several clinico-pathological parameters are used to predict  the prognosis of RCC.,OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Insulin Receptor in Clear Cell Renal Cell Carcinoma Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 865in IR expression was statistically significant (Table 2).,OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 866DISCUSSION Prognosis of RCC can be predicted using several well- known prognostic factors.,Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
"Insulin Receptor in Clear Cell Renal Cell Carcinoma Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 867by the glucose transporter type 4 (GLUT-4), to the cell sur - face.32 Insulin resistance in classic insulin-target organs and  the related hyperglycemia and hyperinsulinemia are patho - logic hallmarks of metabolic disorders such as obesity and  type 2 diabetes.6 Several studies have reported an associa - tion between type 2 diabetes and an increase in risk of de - veloping various human cancers, including liver, pancreas,  bladder, breast, and colon.7-12 However, the association be - tween RCC, and type 2 diabetes and/or obesity remains con - troversial.",Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 868translocates into the nucleus following activation by its li - gands40 and SUMOylation mediates this nuclear transloca - tion of IGF-1R.44 IR can be also translocated to the nucleus  to regulate cell proliferation as well as IGF-1R.45 Overex - pression of IR is predictive of poor survival in patients with  lung cancer.46 In our IHC staining, IR was mainly expressed  in the nuclei of tumor cell that was tumor grade-dependent  manner supporting the notion that high IR expression was  associated with the favorable prognostic factors of CCRCC.",OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Insulin Receptor in Clear Cell Renal Cell Carcinoma Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 869sis.,Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 870274-83.,Non-OADS,/arxiv_data1/oa_pdf/65/9a/ymj-55-861.PMC4075388.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 871Can Ultrasound Be as a Surrogate Marker for Diagnosing a Papillary  Thyroid Cancer?,Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We investigated the merit of ultrasound (US) features and BRAFV600E mu- tation as an additional study of cytology and compared the diagnostic performances  of cytology alone, cytology with US correlation, cytology with BRAFV600E mutation,  and a combination of cytology, US, and BRAFV600E mutation all together.",Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
"US-guided fine-needle aspiration (FNA) has been wide -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.871 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):871-878, 2014",Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 872formed consent for inclusion in this study was waived.,Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
US and BRAF Mutation for Diagnosing PTC Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 873formed real-time US.,Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 874The mean age and gender of the patients were not associat - ed with malignancy ( p=0.569 and p=0.244, respectively).",Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
US and BRAF Mutation for Diagnosing PTC Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 875Table 2.,Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 876contribute to the transformation of malignant follicular cells.,Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
"US and BRAF Mutation for Diagnosing PTC Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 877racy and specificity, they can decrease the diagnostic perfor - mance.",Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 878proving the fine-needle aspiration diagnosis of thyroid nodules.,Non-OADS,/arxiv_data1/oa_pdf/21/66/ymj-55-871.PMC4075389.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 879Pathologic Spectrum of Lymphocytic Infiltration and Recurrence  of Papillary Thyroid Carcinoma Hyun Gi Kim,1 Eun-Kyung Kim,1 Kyung Hwa Han,2 Hyunki Kim,3 and Jin Young Kwak1 Departments of 1Radiology and 3Pathology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul;  2Biostatistics Collaboration Unit, Medical Research Center, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study was to investigate the prognosis of papillary thy - roid carcinoma (PTC) patients according to different pathologic grades of lympho - cytic thyroiditis (LT).",Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
"2-10 Whereas several reports  concluded that better prognosis was shown in the patients with the two diseases at  the same time,4,6,7,11 the other reports conclude that HT was no significant prognos -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.879 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):879-885, 2014",Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 880categorized as iso- or hypoechogenicity (which was defined  as iso- or hypoechogenic compared to the normal thyroid  gland) and marked hypoechogenicity (which was defined as  hypoechogenic compared to the strap muscle).,Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
Lymphocytic Infiltration and Thyroid Carcinoma Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 881square test for categorical variables to compare clinicopath - ologic characteristics among the two different groupings.,Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 882ther L T nor HT was an independent predictor of recurrence.,OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
"Lymphocytic Infiltration and Thyroid Carcinoma Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 883cells.24 Although its nature remains uncertain, studies re - garding the relationship between CLT or HT and PTC have  been reported.",Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 884there was a relatively small number of the study population  to compare disease free survival between each group of pa - tients.,Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
Lymphocytic Infiltration and Thyroid Carcinoma Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 885cellular proliferative activity and cell death in chronic thyroiditis  and thyroid papillary carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/cf/99/ymj-55-879.PMC4075390.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 886A Novel Synthetic Compound 3-Amino-3-(4-Fluoro-Phenyl)-1H- Quinoline-2,4-Dione (KR22332) Exerts a Radioprotective Effect  via the Inhibition of Mitochondrial Dysfunction and Generation  of Reactive Oxygen Species Seung Jae Baek,1* Jae Won Chang,2,3* Keun Hyung Park,2,3 Garp Yeol Yang,4  Hye Sook Hwang,2,3 Yoon Woo Koh,5 Young-Sik Jung,4 and Chul-Ho Kim2,3 1Department of Otolaryngology-Head and Neck Surgery, Yonsei University Wonju College of Medicine, Wonju;  2Department of Otolaryngology and 3Center for Cell Death Regulating Biodrug, School of Medicine, Ajou University, Suwon; 4Bio-Organic Science Division, Korea Research Institute of Chemical Technology, Daejeon; 5Department of Otorhinolaryngology, Yonsei Head and Neck Cancer Clinic, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Acute side effects of radiation such as oral mucositis are observed in  most patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
"OM is especially prevalent in patients Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.886 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):886-894, 2014",Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
"Protection of KR22332 on Radiation Induced Mucositis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 887ation-induced OM: the novel synthetic compound 3-amino- 3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione (KR22332).",Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 888KR22332 (10 μg/mL) for 24 h. The stained cells were ana - lyzed under a fluorescence microscope (400×; Carl Zeiss,  Oberkochen, Germany); the number of TUNEL-positive  cells was determined in triplicate.",OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
Protection of KR22332 on Radiation Induced Mucositis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 889(Fig.,Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 890ment.,Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
Protection of KR22332 on Radiation Induced Mucositis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 891dependent manner.,Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 892diotherapy often suffer from altered taste, pain, dry mouth,  decreased appetite, and ulcers owing to OM, which results in  a significantly decreased quality of life and prognosis.7 De- spite many advances aimed at treating or preventing OM, the  treatment options remain limited.8 Therefore, novel agents to  prevent and mitigate the development of OM in patients  during head and neck cancer treatment are clearly needed.",Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
Protection of KR22332 on Radiation Induced Mucositis Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 893signaling pathways are involved in the pathogenesis of ra - diation-induced mucositis.,Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 894cer: involvement of A TM-dependent p53 expression.,Non-OADS,/arxiv_data1/oa_pdf/e4/a4/ymj-55-886.PMC4075391.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 895The Effect of Ablation for Paroxysmal Atrial Fibrillation on Left  Atrial Volume and Function: A One-Year Follow-Up Study Jung Yeon Chin1 and Ho-Joong Youn2 1Division of Cardiology, Eulji University School of Medicine, Daejeon; 2Cardiovascular Center, Division of Cardiology, Department of Internal Medicine, Seoul St. Mary ’s Hospital,  College of Medicine, The Catholic University of Korea, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The effect of radiofrequency catheter ablation (RFCA) on left atrial  (LA) volume and function in patients with paroxysmal atrial fibrillation (PAF) has  not been extensively studied.",Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
"Because patients with paroxysmal AF have relatively Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.895 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):895-903, 2014",Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
Jung Y eon Chin and Ho-Joong Y oun Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 896od.,Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
Effect of Ablation on Left Atrium Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 897cardiogram.,Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
"Jung Y eon Chin and Ho-Joong Y oun Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 898ameters of the AF group were similar to those of SR group,  but were significantly longer 3 months after RFCA.",Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
"Effect of Ablation on Left Atrium Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 899astolic volume indices after 1 year only showed a differ - ence in trend, though without statistical significance.",OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
"Jung Y eon Chin and Ho-Joong Y oun Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 900max=49.4 mL, the sensitivity of a large LA Vmax (>49 mL)  for predicting AF recurrence was 89.3% in 26 of 29 pa - tients with AF recurrence and the specificity was 56.7% in  35 of 61 patients.",Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
Effect of Ablation on Left Atrium Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 901to induce a reduction in LA Vmax by three-dimensional  echocardiography.,Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
Jung Y eon Chin and Ho-Joong Y oun Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 902tients with paroxysmal AF.,Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
"Effect of Ablation on Left Atrium Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 903Pellikka PA, et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/14/ymj-55-895.PMC4075392.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 904Coronary Flow Reserve in the Remote Myocardium Predicts Left  Ventricular Remodeling Following Acute Myocardial Infarction Rongchao Cheng,1 Guoqian Wei,1 Longhao Yu,1 Zhendong Su,1 Li Wei,1  Xiuping Bai,1 Jiawei Tian,2 and Xueqi Li1 1Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Heilongjiang Province; 2Department of Echocardiology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang Province, China.",Non-OADS,/arxiv_data1/oa_pdf/14/d9/ymj-55-904.PMC4075393.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Coronary flow reserve (CFR) in the non-infarcted myocardium is often im - paired following acute myocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/14/d9/ymj-55-904.PMC4075393.pdf
"Key Words:    Myocardial infarction, microvascular dysfunction, left ventricular re - modeling INTRODUCTION Restoration of adequate tissue perfusion is the goal of reperfusion therapy.1 Microvas - cular dysfunction in the infarcted myocardium is known to play a functional role in  increasing infarct size, hindering left ventricular function and promoting left ventricu - lar remodeling (L VR) during the chronic phases of myocardial infarction.2 However,  microvascular function has also been reported as impaired even in the remote regions  supplied by normal coronary arteries.3 Nevertheless, the clinical significance of mi - crovascular dysfunction in the remote region has not yet been fully examined.4 Micro - vascular flow in humans is difficult to observe, and the methods of measuring micro -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.4.904 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(4):904-911, 2014",Non-OADS,/arxiv_data1/oa_pdf/14/d9/ymj-55-904.PMC4075393.pdf
Microvascular Dysfunction and Left V entricular Remodeling Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 905revascularization with PCI within 12 hours following AMI.,Non-OADS,/arxiv_data1/oa_pdf/14/d9/ymj-55-904.PMC4075393.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014 906tomatically calculated mean acoustic intensity of each ROI  and generated time-intensity curves that were subsequently  fitted to a monoexponential function: y=A (1-e-βt) (q), where  A represents the plateau acoustic intensity and β represents  the rate of acoustic intensity increase and reflects microbub - ble velocity.",OADS,/arxiv_data1/oa_pdf/14/d9/ymj-55-904.PMC4075393.pdf
